Behavioural syndromes associated with physiological disturbances and physical factors

F5_BEHAVE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints F5_ANOREX F5_BULIMIA F5_EATOTH F5_SLEEP F5_SEXDYS F5_MENTPUER F5_ABUNONDEP F5_PHYSBEHOTH	73983
6. Filter based on genotype QC (FinnGen only)	66778

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	F5_BEHAVE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	F5_ANOREX\|F5_BULIMIA\|F5_EATOTH\|F5_SLEEP\|F5_SEXDYS\|F5_MENTPUER\|F5_ABUNONDEP\|F5_PHYSBEHOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Behavioural syndromes associated with physiological disturbances and physical factors based on the number of shared cases.

Similar with more cases:

Psychiatric diseases

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	66778	47406	19372
Unadjusted period prevalence (%)	14.52	16.83	8.88
Median age at first event (years)	50.43	48.82	54.37

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
59237: Matched controls
400488

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N03AG01

ATC

valproic acid; systemic, rectal

2.1

323.0

3346

10875

R00.2

ICD-10 Finland

Palpitations

1.9

323.0

4619

16899

F43.29

ICD-10 Finland

Adaptation disorder UNS

3.1

322.7

1572

3526

N76.0

ICD-10 Finland

Acute vaginitis

2.0

322.2

3921

13553

R05

ICD-10 Finland

Cough

1.5

319.5

11602

54734

R11

ICD-10 Finland

Nausea and vomiting

1.9

319.3

4897

18335

N06AG02

ATC

moclobemide; oral

2.5

319.0

2324

6474

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.5

318.8

1274

2517

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

3.4

316.6

1281

2552

F43.2

ICD-10 Finland

Adjustment disorders

3.5

314.5

1256

2480

A01

ICPC

Pain general/multiple sites

1.8

314.3

5475

21335

J01AA02

ATC

doxycycline; systemic

1.4

313.3

41925

251344

R52.9

ICD-10 Finland

Pain, unspecified

1.8

312.0

5864

23377

Z2445

NOMESCO Finland

Psychologist

2.4

310.3

2370

6751

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

10.4

307.7

2970

2030

N89

ICPC

Migraine

2.6

307.7

2441

6595

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.1

307.7

4072

13668

SPAT1307

SPAT

Psychosocial counselling and guidance

2.4

307.7

4275

12688

R51

ICD-10 Finland

Headache

2.2

307.7

3623

11397

R83

ICPC

Respiratory infection other

1.6

307.7

16309

75024

F50.3

ICD-10 Finland

Atypical bulimia nervosa

52.0

307.7

571

N06AX11

ATC

mirtazapine; oral

7.0

307.7

36709

75326

N06AX12

ATC

bupropion; oral

3.3

307.7

6352

14173

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.6

307.7

4770

9580

J01CA04

ATC

amoxicillin; systemic

1.6

307.7

47603

289682

OAB93, ,

SPAT

3.3

307.7

5851

12850

P76

ICPC

Depressive disorder

3.2

307.7

5721

13113

F41.3

ICD-10 Finland

Other mixed anxiety disorders

3.8

307.7

1218

2199

P99

ICPC

Psychological disorders other

2.9

307.7

2137

5121

R21

ICPC

Throat symptom/complaint

1.7

307.7

13839

61101

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.6

307.7

4067

7963

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

3.7

307.7

1581

2946

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.9

307.7

8482

32103

F33

ICD-10 Finland

Recurrent depressive disorder

4.3

307.7

1989

3205

N05AH03

ATC

olanzapine; systemic

2.9

307.7

4656

11489

SFA10

NOMESCO Finland

One-surface restoration

1.4

307.7

31754

178587

N06AX05

ATC

trazodone; oral

6.2

307.7

2255

2526

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

74.9

307.7

396

N06AA09

ATC

amitriptyline; systemic

2.1

307.7

5012

16717

M01AH05

ATC

etoricoxib; oral

1.6

307.7

35900

195423

P74

ICPC

Anxiety disorder/anxiety state

3.4

307.7

3909

8079

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

307.7

13300

55622

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

307.7

39979

230592

WX290

NOMESCO Finland

Other blockage of nerve

1.5

307.7

28473

152338

N02BF01

ATC

gabapentin; oral

1.9

307.7

5834

22056

N02BE01

ATC

paracetamol; systemic, rectal

1.9

307.7

51909

315336

F43.0

ICD-10 Finland

Acute stress reaction

3.9

307.7

5217

9629

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

3.6

307.7

1311

2495

D10

ICPC

Vomiting

2.1

307.7

3837

12918

3074A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNIHÄIRIÖ]

+∞

307.7

564

N06AX21

ATC

duloxetine; oral

2.6

307.7

8591

24575

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.3

307.7

2371

5003

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.7

307.7

12646

55801

F51.8

ICD-10 Finland

Other nonorganic sleep disorders

7.3

307.7

652

612

Z73.0

ICD-10 Finland

Burn-out

4.6

307.7

3741

5774

F50.2

ICD-10 Finland

Bulimia nervosa

59.5

307.7

790

IHZ05, ,

SPAT

2.6

307.7

3376

9197

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

86.2

307.7

317

L03

ICPC

Low back symptom/complaint

1.8

307.7

18082

80158

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.4

307.7

5546

11971

J01DB01

ATC

cefalexin; oral

1.6

307.7

47626

288778

F32.0

ICD-10 Finland

Mild depressive episode

3.2

307.7

2053

4419

F43.8

ICD-10 Finland

Other reactions to severe stress

4.0

307.7

2304

4022

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

3.6

307.7

2088

4011

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.8

307.7

1648

2991

R01AD58

ATC

fluticasone, combinations; nasal

1.7

307.7

15447

69831

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

307.7

14706

68677

F43

ICD-10 Finland

Reaction to severe stress, and adjustment disorders

4.1

307.7

1791

3006

N03AX16

ATC

[U] pregabalin

1.8

307.7

12719

53120

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

307.7

10409

46889

F34.1

ICD-10 Finland

Dysthymia

3.4

307.7

2732

5565

N05BA01

ATC

diazepam; systemic, rectal

2.3

307.7

7951

25097

N06AX16

ATC

venlafaxine; oral

3.0

307.7

11671

30363

L01

ICPC

Neck symptom/complaint

1.8

307.7

9815

40244

F51.0

ICD-10 Finland

Nonorganic insomnia

+∞

307.7

50015

F50.9

ICD-10 Finland

Eating disorder, unspecified

58.4

307.7

1451

172

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.3

307.7

1842

3853

F43.00

ICD-10 Finland

Acute stress reaction mild

3.1

307.7

1669

3754

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

307.7

5647

21841

N03AE01

ATC

clonazepam; systemic

2.4

307.7

3169

9275

N01

ICPC

Headache

2.0

307.7

7730

28120

F41

ICD-10 Finland

Other anxiety disorders

4.0

307.7

1410

2410

R74

ICPC

Upper respiratory infection acute

1.8

307.7

22435

99904

N03AX09

ATC

lamotrigine; oral

2.8

307.7

3437

8473

Z05

ICPC

Work problem

3.4

307.7

2739

5697

P01

ICPC

Feeling anxious/nervous/tense

3.2

307.7

12233

30017

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

307.7

6239

17970

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.3

307.7

1452

3014

L17

ICPC

Foot/toe symptom/complaint

1.5

307.7

17100

83849

KMAK, ,

NOMESCO Finland

1.4

307.7

28623

157044

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.4

307.7

1571

3161

R03AC02

ATC

salbutamol; inhalant

1.6

307.7

32393

169228

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

3.8

307.7

2296

4154

D11

ICPC

Diarrhoea

2.0

307.7

8030

28676

J01FA10

ATC

azithromycin; systemic

1.5

307.7

33102

185413

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

307.7

31786

174076

N06BA04

ATC

methylphenidate; oral

3.1

307.7

2679

6007

F41.1

ICD-10 Finland

Generalized anxiety disorder

3.8

307.7

4982

9500

78410

ICD-8 Finland

Symptoms referable to upper gastro-intestinal tract, Emesis

+∞

307.7

366

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

307.7

42040

244519

F51.2

ICD-10 Finland

Nonorganic disorder of the sleep-wake schedule

10.7

307.7

661

421

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.8

307.7

2896

7290

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.1

307.7

3702

12077

P02

ICPC

Acute stress reaction

3.3

307.7

4660

10012

N06AA06

ATC

trimipramine; systemic

5.0

307.7

1762

2465

F32

ICD-10 Finland

Depressive episode

3.6

307.7

4811

9621

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.0

307.7

34807

164749

P01AB01

ATC

metronidazole; oral, rectal

1.4

307.7

21276

112292

OAB48, ,

SPAT

1.7

307.7

10659

45575

P25

ICPC

Phase of life problem adult

2.5

307.7

2908

8089

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

307.7

15552

68862

N06AX22

ATC

agomelatine; oral

4.9

307.7

2083

2986

N05AH04

ATC

quetiapine; oral

5.1

307.7

19177

34353

N05CD07

ATC

temazepam; oral

2.7

307.7

6854

18474

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

5.8

307.7

4242

5285

R42

ICD-10 Finland

Dizziness and giddiness

1.6

307.7

12114

55969

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.8

307.7

1107

1578

N07BB01

ATC

disulfiram; oral

2.7

307.7

2728

6963

R53

ICD-10 Finland

Malaise and fatigue

2.2

307.7

17525

63660

Z71.8

ICD-10 Finland

Other specified counselling

1.8

307.7

21932

98404

M25.5

ICD-10 Finland

Pain in joint

1.7

307.7

20214

91494

M54

ICD-10 Finland

Dorsalgia

2.0

307.7

7969

29557

D01

ICPC

Abdominal pain/cramps general

1.8

307.7

7697

29978

N06AB04

ATC

citalopram; systemic

2.4

307.7

13934

45369

R01AD12

ATC

fluticasone furoate; nasal

1.6

307.7

18736

90486

N04BC05

ATC

pramipexole; oral

2.3

307.7

4151

12693

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.6

307.7

12259

27367

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.0

307.7

3888

6839

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

307.7

15270

63404

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.4

307.7

1767

3547

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

307.7

7291

28356

M03BX02

ATC

tizanidine; oral

1.8

307.7

37216

194030

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

307.7

14680

70483

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.1

307.7

7110

16805

F51

ICD-10 Finland

Nonorganic sleep disorders

7.0

307.7

5265

5498

F50.1

ICD-10 Finland

Atypical anorexia nervosa

77.7

307.7

682

F41.8

ICD-10 Finland

Other specified anxiety disorders

4.0

307.7

2827

5013

G44.2

ICD-10 Finland

Tension-type headache

2.1

307.7

8956

31569

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

307.7

13988

63720

N05AA02

ATC

levomepromazine; systemic

3.5

307.7

2645

5329

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

307.7

29439

163259

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

307.7

24507

124324

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.5

307.7

2708

5423

M01AB05

ATC

diclofenac; systemic, rectal

1.5

307.7

36507

205790

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.4

307.7

1850

3776

OAB43, ,

SPAT

1.9

307.7

22330

96120

N03AX12

ATC

[U] gabapentin; oral

1.8

307.7

8671

34846

ZY010

NOMESCO Finland

Hospital outpatient

2.5

307.7

3418

9467

N05BE01

ATC

buspirone; oral

3.2

307.7

1851

4048

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

4.0

307.7

10264

19855

F90.0

ICD-10 Finland

Disturbance of activity and attention

3.1

307.7

3074

6844

R01AD09

ATC

mometasone; nasal

1.5

307.7

26379

137061

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.6

307.7

2095

4045

A98

ICPC

Health maint/preventive medicine

3.1

307.7

57836

372692

N06AA12

ATC

doxepin; systemic

3.2

307.7

3140

6887

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

97.2

307.7

513

N05AF03

ATC

chlorprothixene; systemic

3.1

307.7

1580

3533

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.4

307.7

1964

3968

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

4.1

307.7

10830

20846

F50.8

ICD-10 Finland

Other eating disorders

46.6

307.7

547

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

307.7

17925

82566

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.8

307.7

6811

27062

SPAT1240

SPAT

Therapeutic discussion

2.5

307.7

7860

22837

M79.6

ICD-10 Finland

Pain in limb

1.8

307.7

27377

127812

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

307.7

25930

125445

SFA20

NOMESCO Finland

Two-surface restoration

1.4

307.7

33660

190792

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.6

307.7

3901

7697

A04

ICPC

Weakness/tiredness general

2.0

307.7

10166

38009

R06AE07

ATC

cetirizine; oral

1.4

307.7

24704

132535

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.9

307.7

7746

20003

P03

ICPC

Feeling depressed

3.0

307.7

8939

22711

K02.1

ICD-10 Finland

Caries of dentine

1.5

307.7

34855

196317

G43

ICD-10 Finland

Migraine

2.4

307.7

3592

10535

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.0

307.7

5678

19811

N06AB06

ATC

sertraline; oral

3.0

307.7

9183

23432

F50.0

ICD-10 Finland

Anorexia nervosa

165.7

307.7

893

A02BC05

ATC

esomeprazole; systemic

1.5

307.7

21823

111047

N05BA04

ATC

oxazepam; oral

3.2

307.7

21127

59139

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.1

307.7

2349

5204

M54.5

ICD-10 Finland

Low back pain

1.9

307.7

23861

103460

N06AX03

ATC

mianserin; oral

3.9

307.7

3433

6259

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

307.7

3278

10278

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.5

307.7

1283

2495

M01AE02

ATC

naproxen; oral, rectal

1.5

307.7

32343

175942

P29

ICPC

Psychological sympt/compl other

3.0

307.7

6434

15810

N06AB03

ATC

fluoxetine; oral

2.7

307.7

8682

23808

A03

ICPC

Fever

1.6

307.7

10333

47031

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.9

307.7

7337

27193

G47.9

ICD-10 Finland

Sleep disorder, unspecified

4.1

307.7

2335

4009

P15

ICPC

Chronic alcohol abuse

2.9

307.7

1953

4650

C07AA05

ATC

propranolol; systemic

2.3

307.7

13848

47690

OAB91, ,

SPAT

2.5

307.7

5447

15322

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.1

307.7

19015

72711

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.2

307.7

3169

6867

A02BC02

ATC

pantoprazole; systemic

1.6

307.7

38268

212565

N05CF02

ATC

zolpidem; oral

4.1

307.7

16102

33224

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.7

307.7

1730

3245

N06AB10

ATC

escitalopram; oral

3.0

307.7

17417

48920

P06

ICPC

Sleep disturbance

5.1

307.7

14536

23804

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.9

307.7

2032

4787

M01AE01

ATC

ibuprofen; systemic, rectal

1.8

307.7

52705

327397

R06.0

ICD-10 Finland

Dyspnoea

1.5

307.7

14077

67243

N06AB05

ATC

paroxetine; oral

2.6

307.7

3824

10305

Z01.7

ICD-10 Finland

Laboratory examination

1.6

307.7

9385

41305

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

+∞

307.7

4987

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.9

307.7

6160

23427

OAA81, ,

SPAT

2.9

307.7

2804

6674

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

307.7

11874

47355

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

307.7

43615

247483

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.2

307.7

1900

4165

SPAT1283

SPAT

Restricted health certificate

1.9

307.7

11467

45958

K30

ICD-10 Finland

Functional dyspepsia

1.8

307.7

6446

25556

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.5

307.7

4216

11911

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

33.1

307.7

433

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

307.7

10470

43982

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.4

307.7

2465

4986

Z01.2

ICD-10 Finland

Dental examination

1.4

307.7

27192

148752

M79.1

ICD-10 Finland

Myalgia

1.9

307.7

9139

35759

N05AX12

ATC

aripiprazole; systemic

2.8

307.7

2923

7270

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.6

307.7

1343

2539

OAA65, ,

SPAT

2.7

307.7

15682

47506

R05

ICPC

Cough

1.5

307.7

13824

67407

R06AX27

ATC

desloratadine; oral

1.6

307.7

16985

82233

G43.9

ICD-10 Finland

Migraine, unspecified

2.3

307.7

3966

12376

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

307.7

10845

44552

N06AX26

ATC

vortioxetine; oral

3.5

307.7

6930

14692

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

307.7

23109

104848

L02

ICPC

Back symptom/complaint

1.8

307.7

6104

24181

G47.3

ICD-10 Finland

Sleep apnoea

1.7

307.7

12972

56558

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

307.7

16812

83954

R51.80

ICD-10 Finland

Headache

2.1

307.7

10524

37952

N05CF01

ATC

zopiclone; oral

3.8

307.7

25961

68646

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

4.2

307.7

2914

4850

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.3

307.7

2327

4831

GD1AA, ,

SPAT

1.6

307.7

9505

41815

F32.1

ICD-10 Finland

Moderate depressive episode

3.7

307.7

5494

10805

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

307.7

26637

141179

J02AC01

ATC

fluconazole; systemic

1.6

307.7

22020

110507

N02AX02

ATC

tramadol; systemic, rectal

1.6

307.7

23280

117005

N05BA12

ATC

alprazolam; oral

2.4

307.7

6092

18339

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.4

307.7

1341

2093

N02BF02

ATC

pregabalin; oral

2.1

307.7

3997

13089

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

3.2

307.7

1733

3695

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

307.1

14344

71237

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.9

306.6

4228

15268

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

305.3

13157

64276

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.5

302.8

11464

54489

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

302.1

3239

10664

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.2

301.3

925

1503

D19

ICPC

Teeth/gum symptom/complaint

1.4

296.8

17565

91132

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

4.8

295.9

775

1100

F40.1

ICD-10 Finland

Social phobias

2.8

294.9

1671

4088

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

2.0

292.4

3807

13467

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

290.6

29101

164978

-1, ,

NOMESCO Finland

1.4

289.3

18466

97012

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

287.6

11426

54783

F61.0

ICD-10 Finland

Mixed personality disorders

3.5

284.7

1113

2165

L12

ICPC

Hand/finger symptom/complaint

1.6

284.6

9588

44340

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

284.0

11571

55751

R01AD08

ATC

fluticasone; nasal

1.4

282.2

15197

77331

F43.01

ICD-10 Finland

Acute stress reaction moderate

3.5

281.5

1119

2202

X23

ICPC

Fear sexually transm dis female

2.1

278.0

3107

10386

D09

ICPC

Nausea

2.1

276.8

2928

9581

P58

ICPC

Psychological, Therapeutic counselling/listening

3.0

274.4

1408

3255

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.5

273.8

1060

2048

F45.8

ICD-10 Finland

Other somatoform disorders

1.9

271.7

3953

14514

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

271.1

5379

21732

L08

ICPC

Shoulder symptom/complaint

1.5

270.2

12012

58824

-1, ,

ICD-10 Finland

2.1

269.5

2822

9196

P86

ICPC

Anorexia nervosa/bulimia

14.5

268.2

309

145

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.4

267.8

2131

6180

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

266.9

22109

120942

M54.6

ICD-10 Finland

Pain in thoracic spine

1.8

262.9

4198

15880

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

262.4

22747

125238

N30.0

ICD-10 Finland

Acute cystitis

1.5

262.4

9119

42380

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.4

261.8

1997

5679

M54.2

ICD-10 Finland

Cervicalgia

1.8

261.6

4371

16770

R12

ICD-10 Finland

Heartburn

1.8

261.3

4696

18422

D73

ICPC

Gastroenteritis presumed infection

2.3

258.9

2199

6565

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

258.1

37834

225818

SPAT1243

SPAT

Psychiatric/psychological examination

2.6

254.9

1660

4369

S06.0

ICD-10 Finland

Concussion

1.7

251.2

5793

24363

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.1

251.0

1203

2669

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.1

250.8

2679

8793

E66.8

ICD-10 Finland

Other obesity

2.0

250.3

3131

10902

J45

ICD-10 Finland

Asthma

1.7

249.1

5611

23449

N05AX08

ATC

risperidone; systemic

1.8

247.9

4101

15675

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

246.8

6523

28401

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3.2

246.6

1089

2296

A02BC03

ATC

lansoprazole; oral

1.4

246.4

13536

68813

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

246.2

6406

27782

N06AB08

ATC

fluvoxamine; oral

2.8

245.8

1410

3470

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

245.1

6446

28029

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

244.7

11825

58685

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

244.5

4261

16547

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.0

242.9

1251

2897

R52.2

ICD-10 Finland

Other chronic pain

2.3

242.7

2056

6128

IHZ04, ,

SPAT

3.0

241.4

1188

2678

R03DC03

ATC

montelukast; oral

1.5

240.9

8643

40368

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.8

240.5

1364

3336

J01CA08

ATC

pivmecillinam; oral

1.4

240.1

20922

114796

R02

ICPC

Shortness of breath/dyspnoea

1.6

240.1

6968

31020

IBA01, ,

SPAT

2.8

237.9

1339

3261

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.9

237.4

1245

2913

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

237.2

6770

30013

A97

ICPC

No disease

1.5

236.7

10684

52284

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

235.6

6185

26863

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

235.4

21559

119093

M79.7

ICD-10 Finland

Fibromyalgia

2.3

235.3

1946

5738

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

235.0

2968

10364

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

234.1

3925

15056

F32.8

ICD-10 Finland

Other depressive episodes

3.2

233.6

1040

2204

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

233.6

6180

26890

N30

ICD-10 Finland

Cystitis

1.7

233.1

4522

18115

Z2221

NOMESCO Finland

Medical doctor

1.4

232.5

13581

69676

L15

ICPC

Knee symptom/complaint

1.4

232.3

13127

66950

N05AN01

ATC

lithium; oral

2.7

232.3

1393

3511

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

232.2

9604

46168

K08.80

ICD-10 Finland

Toothache NOS

1.7

231.1

5049

20904

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.6

230.8

5899

25442

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

229.8

10677

52502

A02BC01

ATC

omeprazole; systemic

1.4

227.4

13120

67120

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.0

225.0

1129

2574

R07.0

ICD-10 Finland

Pain in throat

1.8

224.4

4180

16540

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

223.9

13958

72339

E0000UV, ,

ATC

1.3

223.5

22277

124343

N17

ICPC

Vertigo/dizziness

1.6

223.3

6422

28492

N06BA12

ATC

lisdexamfetamine; oral

3.7

223.2

800

1463

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.3

223.0

958

1984

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.8

222.7

3758

14436

Z3231

NOMESCO Finland

Registered nurse

1.4

222.0

13321

68567

F51.1

ICD-10 Finland

Nonorganic hypersomnia

24.8

221.1

208

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

109.8

220.0

162

F31

ICD-10 Finland

Bipolar affective disorder

3.6

219.5

830

1577

Z2446

NOMESCO Finland

Social worker

1.9

218.6

3276

12118

H01

ICPC

Ear pain/earache

1.6

217.7

6644

29875

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

3.6

217.6

832

1593

F33.8

ICD-10 Finland

Other recurrent depressive disorders

4.4

217.2

628

971

K59.0

ICD-10 Finland

Constipation

2.0

217.2

2805

9866

J20

ICD-10 Finland

Acute bronchitis

1.6

215.9

5485

23597

E66

ICD-10 Finland

Obesity

1.9

215.6

3054

11087

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

3.7

215.3

769

1403

A05

ICPC

Feeling ill

1.8

213.6

3612

13878

P16

ICPC

Acute alcohol abuse

3.1

212.6

998

2186

D06

ICPC

Abdominal pain localized other

1.7

212.4

4879

20448

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.4

211.8

886

1803

R07

ICPC

Sneezing/nasal congestion

1.8

210.2

3729

14535

U02

ICPC

Urinary frequency/urgency

1.5

208.7

7551

35230

M77.1

ICD-10 Finland

Lateral epicondylitis

1.7

208.6

4310

17551

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.4

208.3

842

1675

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

6.9

205.2

376

368

IBZ05

NOMESCO Finland

Evaluation of patient with eating disorder

57.4

204.3

161

O99.80

ICD-10 Finland

The fear of childbirth

2.0

203.4

2336

7870

R07.3

ICD-10 Finland

Other chest pain

1.6

203.3

5143

22083

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.1

202.5

983

2197

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

201.9

7214

33546

SPAT1051

SPAT

Guidance regarding sleep disorders

3.2

201.4

920

1981

SDA03

NOMESCO Finland

Periodontal treatment

1.3

201.2

22146

124793

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.8

200.3

3766

14924

SGA01

NOMESCO Finland

Emergency treatment

1.5

200.1

8775

42535

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

199.9

3297

12562

G03DB01

ATC

dydrogesterone; oral

1.6

199.1

6021

26977

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

198.9

3236

12278

R06AX22

ATC

ebastine; oral

1.5

198.5

8704

42186

N02CC07

ATC

frovatriptan; oral

2.1

197.6

2130

7005

N05AB03

ATC

perphenazine; systemic, rectal

2.3

197.6

1728

5218

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.4

197.5

818

1654

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

197.4

7127

33203

D82

ICPC

Teeth/gum disease

1.3

196.3

20609

115243

H02AB06

ATC

prednisolone; systemic

1.3

194.9

23971

136964

J01DA01

ATC

[U] cefalexin

1.3

194.2

32013

190189

T74.1

ICD-10 Finland

Physical abuse

2.7

194.2

1144

2855

S18

ICPC

Laceration/cut

1.3

192.6

23815

136097

EBA00

NOMESCO Finland

Extraction of tooth

1.3

192.6

19605

109065

OAA67, ,

SPAT

1.4

191.7

9655

47997

SPAT1308

SPAT

Sexual health counselling

1.5

191.3

6306

28790

N05BA02

ATC

chlordiazepoxide; systemic

2.7

190.5

1123

2803

Z00.0

ICD-10 Finland

General medical examination

1.4

190.0

9764

48706

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

189.7

9101

44829

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

189.5

15281

82112

IBA03

NOMESCO Finland

Psychotherapy evaluation

3.9

188.7

632

1099

IGY02, ,

SPAT

2.9

188.6

1012

2398

J01FA06

ATC

roxithromycin; oral

1.3

188.6

19374

107834

P18

ICPC

Medication abuse

5.1

188.6

466

627

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

188.4

4426

18633

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.1

186.9

2077

6909

A02BC04

ATC

rabeprazole; oral

1.7

186.8

4309

18051

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

186.5

5161

22628

A11

ICPC

Chest pain NOS

1.7

185.7

4129

17130

SFA30

NOMESCO Finland

Three-surface restoration

1.3

185.6

21845

123810

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

183.8

4159

17332

M01AC06

ATC

meloxicam; systemic, rectal

1.3

183.3

17092

93733

Z71.9

ICD-10 Finland

Counselling, unspecified

1.7

182.9

4213

17640

S29

ICPC

Skin symptom/complaint other

1.4

182.7

10365

52569

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

182.7

15787

85616

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

181.9

4952

21619

J06

ICD-10 Finland

Acute upper respiratory infections of multiple and unspecified sites

1.9

181.9

2474

8848

F10.24

ICD-10 Finland

Alcohol depence active use

3.1

181.5

872

1937

Z30.1

ICD-10 Finland

Insertion of (intrauterine) contraceptive device

1.5

181.5

5950

27113

SPAT1310

SPAT

Counselling related to known health issue

1.3

180.5

15828

85990

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.8

180.4

3059

11746

L16

ICPC

Ankle symptom/complaint

1.5

180.2

6283

29011

K02.0

ICD-10 Finland

Caries limited to enamel

1.4

179.3

11248

58000

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

179.1

6824

32097

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

3.0

179.1

876

1967

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

178.4

12203

63808

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.6

178.3

668

1261

F60.5

ICD-10 Finland

Anankastic personality disorder

3.5

178.1

696

1353

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

178.0

3727

15208

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

177.5

3987

16577

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

177.3

17939

99407

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

177.3

3821

15712

Z3226

NOMESCO Finland

Physiotherapist

1.4

177.0

8353

40963

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.8

176.0

3081

11941

EB1AA, ,

SPAT

1.7

175.0

3304

13094

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

174.6

8659

42840

ZXE00

NOMESCO Finland

One hour or less

1.3

174.4

18930

105857

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.1

173.8

837

1862

R30.0

ICD-10 Finland

Dysuria

2.0

173.6

2280

8055

K58

ICD-10 Finland

Irritable bowel syndrome

2.3

173.1

1513

4565

A23

ICPC

Risk factor NOS

1.6

173.0

5255

23524

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

172.8

19853

111834

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

172.7

2611

9669

K04.08

ICD-10 Finland

Other specified pulpit

1.6

172.3

4255

18125

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

170.9

17107

94541

F41.00

ICD-10 Finland

Moderate panic disorder

2.9

170.8

908

2140

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

170.6

6036

27936

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.8

170.6

953

2310

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

169.9

11420

59474

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.2

169.3

1695

5411

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.7

169.1

3174

12553

R01AD59

ATC

mometasone, combinations; nasal

1.7

168.9

3632

14920

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.7

167.8

1017

2576

M54.8

ICD-10 Finland

Other dorsalgia

1.9

167.4

2405

8757

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.8

167.4

3130

12365

IGY99, ,

SPAT

2.4

167.3

1291

3684

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.6

167.3

4403

19046

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

166.8

9748

49594

T82

ICPC

Obesity

1.9

166.7

2289

8209

AA1AD

NOMESCO Finland

CT of head and brain

1.3

165.9

13096

69879

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

165.9

4381

18965

J01EA01

ATC

trimethoprim; systemic

1.4

165.1

12136

64055

F52.2

ICD-10 Finland

Failure of genital response

2.6

164.9

1095

2907

N03AX11

ATC

topiramate; oral

2.4

164.5

1301

3755

K07.60

ICD-10 Finland

Snapping jaw

1.8

163.9

2748

10508

F53.0

ICD-10 Finland

Mild mental and behavioural disorders associated with the puerperium, not elsewhere classified

20.0

163.6

165

R03BA02

ATC

budesonide; inhalant

1.4

163.0

8758

43899

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.9

162.5

2236

8023

N02CC04

ATC

rizatriptan; oral

1.8

162.4

2833

10962

U07

ICPC

Urine symptom/complaint other

1.6

161.8

4060

17351

M77.4

ICD-10 Finland

Metatarsalgia

1.7

161.4

3106

12368

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.8

160.7

2766

10660

X58

ICD-10 Finland

Exposure to other specified factors

1.4

160.3

7737

38031

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

160.0

14854

81069

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.7

159.7

3215

12964

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

159.7

13479

72568

H92.0

ICD-10 Finland

Otalgia

1.7

158.7

3424

14070

SPAT1263

SPAT

Sampling

1.3

158.7

21215

121483

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.9

158.4

855

2033

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.6

157.6

4031

17305

SPAT1192

SPAT

Gynaecological examination

1.6

156.6

4555

20164

S80.0

ICD-10 Finland

Contusion of knee

1.6

156.3

3959

16953

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

156.3

4589

20358

R03BA05

ATC

fluticasone; inhalant

1.4

155.7

8931

45230

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.5

155.5

1107

3041

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

155.1

14630

79954

78450

ICD-8 Finland

Symptoms referable to upper gastro-intestinal tract, Haematemesis

+∞

154.9

174

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.8

154.9

864

2092

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.5

154.9

4910

22161

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

3.3

154.9

668

1387

WX110, ,

SPAT

1.7

154.6

2891

11413

SPAT1312

SPAT

General health counselling

1.3

154.6

16081

89057

U01

ICPC

Dysuria/painful urination

1.6

154.0

4004

17254

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

153.9

18510

104464

78419

ICD-8 Finland

Symptoms referable to upper gastro-intestinal tract, Nausea NUD

+∞

153.2

172

N05CD02

ATC

nitrazepam; oral

3.2

153.1

700

1508

H03AA01

ATC

levothyroxine sodium; systemic

1.4

153.1

10893

57107

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

3.7

153.0

554

1021

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

2.7

153.0

905

2263

J01FA09

ATC

clarithromycin; systemic

1.3

152.6

15502

85545

R06.5

ICD-10 Finland

Mouth breathing

1.6

151.8

4303

18928

X15

ICPC

Vaginal symptom/complaint other

1.9

151.5

2145

7768

J01

ICD-10 Finland

Acute sinusitis

1.7

151.5

2914

11597

W12

ICPC

Contraception intrauterine

1.5

151.2

4701

21121

Z30.0

ICD-10 Finland

General counselling and advice on contraception

1.7

151.1

2984

11964

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

151.0

2401

9027

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

150.6

13617

73919

G43.3

ICD-10 Finland

Complicated migraine

2.6

150.5

963

2509

N05BA06

ATC

lorazepam; systemic, sublingual

1.9

150.2

2224

8174

N02CC03

ATC

zolmitriptan; nasal, oral

1.8

149.1

2592

10014

R06AE09

ATC

levocetirizine; oral

1.4

148.9

7089

34718

K04.0

ICD-10 Finland

Pulpitis

1.5

148.5

4731

21366

R4110

NOMESCO Finland

Physiotherapy

1.3

148.2

13125

71011

B02AA02

ATC

tranexamic acid; systemic

1.4

148.2

6920

33767

DM1QA, ,

SPAT

1.9

148.0

2256

8368

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

147.7

2741

10794

C09CA06

ATC

candesartan; oral

1.3

146.9

11578

61585

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.5

146.1

4581

20612

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.6

145.8

548

1037

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.7

145.6

893

2276

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

4.0

145.6

471

798

A02BA02

ATC

ranitidine; systemic

1.4

144.9

7984

40107

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.5

144.3

1046

2898

R09

ICPC

Sinus symptom/complaint

1.6

143.9

4210

18646

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

6.3

143.9

286

308

D12

ICPC

Constipation

2.0

143.7

1758

6052

WYA10

NOMESCO Finland

Emergency care or similar visit

1.6

143.5

3656

15666

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.8

143.5

2296

8646

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.7

142.6

2669

10534

L13

ICPC

Hip symptom/complaint

1.4

142.3

8923

45788

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

142.2

10407

54709

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.2

142.2

1320

4084

D07AC01

ATC

betamethasone; topical

1.3

141.8

17962

101765

R35

ICD-10 Finland

Polyuria

1.7

141.5

2995

12234

J01AA07

ATC

tetracycline; systemic

1.4

140.9

7174

35530

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.7

140.9

2767

11072

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.7

140.4

3178

13215

IER01

NOMESCO Finland

Psychoeducation, group

3.8

139.5

487

874

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

4.0

139.2

450

762

N07BA03

ATC

varenicline; oral

1.8

139.1

2412

9308

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.8

139.0

2370

9100

N02CC05

ATC

almotriptan; oral

1.9

138.9

1930

6943

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.5

138.8

5292

24808

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.6

138.5

885

2304

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

138.2

7393

36924

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

137.7

20207

116434

P27

ICPC

Fear of mental disorder

2.8

137.6

770

1868

F29

ICPC

Eye symptom/complaint other

1.5

137.1

5279

24793

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

137.0

5058

23554

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

136.8

5320

25035

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

136.5

14613

80954

Z76

ICD-10 Finland

Persons encountering health services in other circumstances

2.2

136.2

1301

4073

F51.3

ICD-10 Finland

Sleepwalking [somnambulism]

31.3

135.9

120

ICB06, ,

NOMESCO Finland

3.7

135.5

493

912

SPAT1246

SPAT

Screening of depression or other psychiatric problem

1.8

135.0

2217

8415

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

134.9

2370

9181

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

5.5

134.6

306

380

A99

ICPC

Disease/condition unspecnature/site

1.5

134.4

4961

23095

ZY000

NOMESCO Finland

Hospital inpatient

2.9

134.2

728

1736

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

134.2

19057

109287

D02

ICPC

Abdominal pain epigastric

1.6

133.8

3113

13031

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

133.1

3967

17631

J05AB01

ATC

aciclovir; systemic

1.3

133.0

10436

55360

J35.0

ICD-10 Finland

Chronic tonsillitis

1.7

132.3

2657

10693

F50.4

ICD-10 Finland

Overeating associated with other psychological disturbances

54.7

132.2

105

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.2

132.2

604

1301

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

132.1

13906

76803

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

132.0

5141

24191

Z63.4

ICD-10 Finland

Disappearance and death of family member

3.0

131.7

648

1460

WZC00, ,

SPAT

1.4

131.7

7634

38620

Z12

ICPC

Relationship problem with partner

2.5

131.3

942

2597

L11

ICPC

Wrist symptom/complaint

1.5

131.3

4729

21900

J30.19

ICD-10 Finland

Pollen allergy UNS

1.8

131.1

2194

8375

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

130.8

3400

14630

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

130.5

3713

16324

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

130.0

4466

20475

K03.80

ICD-10 Finland

Irradiated enamel

1.7

129.9

2802

11497

M01AH01

ATC

celecoxib; oral

1.4

129.5

7852

40011

R50.9

ICD-10 Finland

Fever, unspecified

1.4

129.4

7266

36553

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

129.4

16251

91725

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

3.3

129.4

549

1128

R03BA01

ATC

beclometasone; inhalant

1.4

129.3

6281

30810

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

128.9

4283

19495

ZYC02, ,

SPAT

1.9

128.8

1728

6141

N02CC06

ATC

eletriptan; oral

1.9

128.6

1766

6326

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

128.2

14697

82005

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

128.0

20599

119664

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

128.0

2074

7837

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.6

128.0

2973

12437

L20.0

ICD-10 Finland

Besnier prurigo

1.6

127.8

3838

17081

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

127.8

11601

62772

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

127.6

6066

29636

F50

ICD-10 Finland

Eating disorders

21.7

127.6

125

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

1.3

127.6

9207

48200

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

127.5

4031

18149

OAA62, ,

SPAT

1.5

127.3

4077

18407

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

126.5

3672

16216

H01.0

ICD-10 Finland

Blepharitis

1.6

126.1

3472

15144

R06AX13

ATC

loratadine; oral

1.4

126.0

7253

36627

H93.1

ICD-10 Finland

Tinnitus

1.6

125.7

3278

14114

EMB10

NOMESCO Finland

Tonsillectomy

1.6

125.6

2943

12337

SPAT1260

SPAT

Consultation of another employee

1.4

125.4

8123

41809

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

125.1

4484

20734

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.6

124.3

3501

15351

R01AD01

ATC

beclometasone; nasal

1.4

124.2

6944

34888

R03AC03

ATC

terbutaline; inhalant

1.4

123.9

6393

31680

ULA02

NOMESCO Finland

Kolposcopy

1.5

123.6

4307

19795

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.7

123.6

2498

10067

G47.8

ICD-10 Finland

Other sleep disorders

2.3

123.1

1002

2929

W14

ICPC

Contraception female other

1.7

122.9

2499

10088

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.5

122.4

840

2267

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

122.3

7014

35382

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.0

122.1

1389

4654

H66.9

ICD-10 Finland

Otitis media, unspecified

1.6

122.0

3447

15122

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

121.8

12957

71524

K04

ICPC

Palpitations/awareness of heart

1.7

121.6

2508

10163

P19

ICPC

Drug abuse

3.1

121.5

584

1298

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

1.5

120.8

4281

19741

Z29

ICPC

Social problem NOS

2.2

120.7

1105

3398

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

3.8

120.4

422

760

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

119.7

8395

43711

EB1VA, ,

NOMESCO Finland

1.3

119.5

9072

47795

IAA01, ,

SPAT

3.1

119.2

553

1203

N94.6

ICD-10 Finland

Dysmenorrhoea, unspecified

2.3

119.1

1025

3070

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

119.1

17234

98691

XQ800

NOMESCO Finland

Prick test

1.6

118.8

3523

15625

NH3AA, ,

SPAT

1.6

118.8

2891

12231

H57.1

ICD-10 Finland

Ocular pain

1.8

118.5

1971

7506

SPAT1301

SPAT

No procedures

1.3

118.1

14756

83038

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.0

118.0

587

1332

M75.8

ICD-10 Finland

Other shoulder lesions

1.8

117.9

1863

6984

SPAT1241

SPAT

Extensive assessment of psychosocial situation

2.8

117.8

676

1663

X14

ICPC

Vaginal discharge

2.1

117.5

1235

4016

G01AA10

ATC

clindamycin; vaginal

1.4

117.4

6360

31761

W11

ICPC

Contraception oral

1.5

117.3

4539

21306

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.7

116.9

2288

9136

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

116.9

4087

18789

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

116.6

12774

70711

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

116.4

3953

18062

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.5

116.2

4134

19072

L04

ICPC

Chest symptom/complaint

1.6

116.1

3079

13303

R52.0

ICD-10 Finland

Acute pain

1.9

115.6

1611

5798

IHZ01, ,

SPAT

2.6

115.5

720

1851

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.3

115.4

15220

86151

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

2.7

115.4

718

1844

Z10.0

ICD-10 Finland

Occupational health examination

1.4

115.2

4994

23957

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.6

115.0

2740

11529

IEY01

NOMESCO Finland

Psychoeducation, individual

3.3

114.8

495

1028

L29.9

ICD-10 Finland

Pruritus, unspecified

2.0

114.8

1349

4574

Z56.6

ICD-10 Finland

Other physical and mental strain related to work

3.4

114.7

469

941

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

4.3

114.6

339

535

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

4.8

114.6

301

429

O80.0

ICD-10 Finland

Spontaneous vertex delivery

1.3

114.0

10029

53910

F43.28

ICD-10 Finland

Adaptive disorder with other predominant symptoms

4.0

113.7

364

612

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

113.6

9063

48054

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.2

113.5

22364

132274

N92.5

ICD-10 Finland

Other specified irregular menstruation

1.9

113.1

1694

6242

G02BA03

ATC

plastic IUD with progestogen

1.4

113.0

5194

25186

NG1AA, ,

SPAT

1.5

112.7

3942

18117

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.8

112.3

2015

7848

N91.1

ICD-10 Finland

Secondary amenorrhoea

2.4

112.0

851

2411

Z73.8

ICD-10 Finland

Other problems related to life-management difficulty

3.1

111.4

537

1196

OAB38, ,

SPAT

2.1

111.2

1199

3937

Z00.8

ICD-10 Finland

Other general examinations

1.5

111.0

3903

17955

NA3BG, ,

SPAT

1.7

111.0

2099

8299

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

110.7

10657

57957

E61.1

ICD-10 Finland

Iron deficiency

2.0

110.1

1381

4793

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

110.0

1626

5966

K03.00

ICD-10 Finland

Approximal wear

1.5

109.7

3795

17398

NA3AA, ,

SPAT

1.8

109.5

1873

7192

ZYC01, ,

SPAT

1.4

109.5

5468

26904

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

109.4

2770

11830

N05AB01

ATC

dixyrazine; systemic

3.0

109.1

542

1229

JN1AE, ,

SPAT

1.8

108.8

1964

7662

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

3.7

108.1

386

705

V03AA01, ,

ATC

2.6

107.9

694

1813

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

107.7

3047

13361

D07AA02

ATC

hydrocortisone; topical

1.4

107.2

6664

34003

SGC10

NOMESCO Finland

Pulp capping

1.5

107.1

4292

20269

IGV01

NOMESCO Finland

Psychiatric network contact

2.8

107.0

603

1469

L86

ICPC

Back syndrome with radiating pain

1.6

107.0

2842

12279

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.5

106.4

4433

21090

UJF32

NOMESCO Finland

Coloscopy

1.3

105.9

11554

63797

N06AA04

ATC

clomipramine; systemic

2.5

105.9

767

2125

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

105.8

2102

8426

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

1.4

105.7

6227

31492

S04

ICPC

Lump/swelling localized

1.4

105.7

5369

26484

F52.0

ICD-10 Finland

Lack or loss of sexual desire

5.5

105.7

240

298

J01AA04

ATC

lymecycline; systemic

1.4

105.7

6330

32102

G03HB01

ATC

cyproterone and estrogen; oral

1.5

105.5

4300

20371

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.7

105.4

2153

8696

K80

ICPC

Cardiac arrhythmia NOS

1.5

104.7

3763

17384

SPAT1238

SPAT

Brief therapy

2.3

104.6

899

2691

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

104.5

5091

24928

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.4

104.5

5104

25003

L18

ICPC

Muscle pain

1.7

104.4

2050

8190

H10

ICD-10 Finland

Conjunctivitis

1.5

104.4

3723

17171

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

3.5

104.3

410

801

WX402

NOMESCO Finland

General anaesthesia

1.3

104.2

10849

59534

J06.89

ICD-10 Finland

Other acute upper respiratory infections of multiple sites

2.0

104.1

1307

4537

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.9

103.9

1443

5187

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

103.8

10070

54753

J04.0

ICD-10 Finland

Acute laryngitis

1.8

103.8

1807

6974

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

103.8

3058

13533

OAA64, ,

SPAT

1.6

103.7

2884

12593

M54.3

ICD-10 Finland

Sciatica

1.6

103.6

2630

11237

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.7

103.5

1938

7639

J01FF01

ATC

clindamycin; systemic

1.3

103.4

12621

70614

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

103.3

11122

61279

C07AB07

ATC

bisoprolol; oral

1.2

103.1

21247

125845

ND2AA, ,

SPAT

1.6

102.9

2734

11810

IHZ02, ,

SPAT

2.3

102.6

822

2386

T05

ICPC

Feeding problem of adult

2.9

102.5

528

1223

F51.5

ICD-10 Finland

Nightmares

13.2

102.5

123

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

102.3

2640

11325

IHZ19, ,

SPAT

2.9

102.2

551

1310

O26.82

ICD-10 Finland

Exhaustion and fatigue pregnancy-related

2.2

102.2

940

2897

N06AA10

ATC

nortriptyline; systemic

2.2

101.7

952

2955

R29

ICPC

Respiratory symptom/complaint other

1.5

101.5

3192

14329

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

3.5

101.5

388

744

L28

ICPC

Limited function/disability (L)

1.3

101.4

7971

42102

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.7

101.3

2078

8402

K05.22

ICD-10 Finland

Acute pericoronitis

1.7

101.2

2276

9431

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

101.2

5292

26226

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.7

101.0

2247

9283

R06AX26

ATC

fexofenadine; oral

1.5

101.0

3148

14105

S21

ICPC

Skin texture symptom/complaint

1.3

101.0

7120

37014

G44.8

ICD-10 Finland

Other specified headache syndromes

2.4

100.8

777

2216

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

3.5

100.7

385

738

J02

ICD-10 Finland

Acute pharyngitis

1.7

100.6

2030

8170

Z34.9

ICD-10 Finland

Supervision of normal pregnancy, unspecified

1.5

100.4

4170

19818

L70.0

ICD-10 Finland

Acne vulgaris

1.8

100.2

1554

5788

N06AX18

ATC

reboxetine; oral

2.9

100.0

520

1211

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.0

99.9

498

1132

WZB00, ,

SPAT

1.4

99.3

5046

24876

LCH11

NOMESCO Finland

Pharmacologic abortion

1.8

99.3

1638

6220

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

99.1

3341

15223

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.8

98.6

1532

5709

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.5

98.2

669

1799

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

3.1

97.9

455

991

F51.4

ICD-10 Finland

Sleep terrors [night terrors]

39.7

97.7

R96

ICPC

Asthma

1.4

97.5

4497

21789

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

97.2

4737

23178

L05

ICPC

Flank/axilla symptom/complaint

1.6

97.2

2901

12870

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

1.5

96.8

4058

19314

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.2

96.5

888

2737

SPAT1389

SPAT

Visit based on need for special support

2.0

96.5

1150

3919

L09

ICPC

Arm symptom/complaint

1.6

96.2

2321

9788

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

96.0

4719

23124

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

3.0

95.9

484

1108

F93.89

ICD-10 Finland

Other childhood emotional disorders

3.3

95.9

416

868

E66.9

ICD-10 Finland

Obesity, unspecified

1.8

95.7

1672

6459

A60.0

ICD-10 Finland

Herpesviral infection of genitalia and urogenital tract

2.1

95.7

962

3074

SFA00

NOMESCO Finland

Small restoration

1.3

95.4

6628

34353

N80.9

ICD-10 Finland

Endometriosis, unspecified

2.2

95.3

878

2708

A06AC51

ATC

ispaghula, combinations; oral

1.7

95.1

2047

8382

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.0

95.0

1092

3673

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

3.7

94.9

337

613

L10

ICPC

Elbow symptom/complaint

1.6

94.6

2662

11651

E03

ICD-10 Finland

Other hypothyroidism

1.6

94.5

2678

11740

K04.09

ICD-10 Finland

Pulpit UNS

1.6

94.4

2247

9444

SBB10

NOMESCO Finland

Dental impressions

1.5

94.3

3348

15418

N62

ICD-10 Finland

Hypertrophy of breast

1.7

94.2

1831

7293

N94.4

ICD-10 Finland

Primary dysmenorrhoea

2.1

94.1

952

3049

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

93.8

2082

8595

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

93.5

11690

65459

F60.8

ICD-10 Finland

Other specific personality disorders

3.4

93.5

378

753

JN3AE, ,

SPAT

1.7

93.2

1888

7606

A06AD11

ATC

lactulose; oral

1.4

93.0

5597

28367

T78.4

ICD-10 Finland

Allergy, unspecified

1.6

92.9

2162

9034

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.4

92.8

4456

21737

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022096) Basophils/Leukocytes in Blood

29326

164864

1.40

321.10

6.4

6.9

0.69

0.68

3.10

27618

155136

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

32143

178262

1.48

307.65

5.6

6.7

10.69

11.38

umol/l

18.79

30538

169809

(3002030) Lymphocytes/Leukocytes in Blood

30171

169965

1.41

307.65

6.3

6.7

29.12

28.18

45.06

28763

161824

(3021960) Folate [Moles/volume] in Serum or Plasma

18977

91419

1.59

307.65

1.8

1.7

20.51

20.02

nmol/l

4.14

16723

78409

(3024731) MCV [Entitic mean volume] in Red Blood Cells

58424

376943

4.49

307.65

25.4

22.5

90.75

90.71

1.58

58136

373395

(3006315) Basophils [#/volume] in Blood

32421

179451

1.49

307.65

6.3

6.6

0.04

e9/l

0.15

28152

155262

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

11901

43873

2.04

307.65

2.1

1.7

1.46

1.43

4.80

10727

38970

(3018010) Neutrophils/Leukocytes in Blood

29829

166724

1.42

307.65

6.2

6.6

56.25

57.07

29.82

28589

159891

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

53788

336887

1.86

307.65

5.1

4.8

4.67

mmol/l

0.08

51335

318297

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

18630

84760

1.71

307.65

1.4

1.3

1.31

1.74

u/ml

6.19

5378

23245

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

27889

145337

1.56

307.65

2.2

2.1

98.41

96.54

pmol/l

8.48

15041

78024

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

6670

24395

1.96

307.65

2.4

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

12566

49004

1.93

307.65

2.6

2.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

11671

44971

1.94

307.65

2.5

2.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

7788

29368

1.91

307.65

2.5

2.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

15964

73478

1.64

307.65

1.5

2.25

2.36

g/l

12.15

10072

46438

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

17698

88225

1.51

307.65

2.4

2.61

2.79

mg/l

23.07

15421

76543

(3015736) pH of Urine

27471

149476

1.45

307.65

3.5

3.4

6.22

0.10

15040

84004

(3035350) Ketones [Presence] in Urine by Test strip

33372

187338

1.47

307.65

4.0

3.8

3.92

3.76

estimate

0.06

6987

38697

(3021601) Nitrite [Presence] in Urine by Test strip

33090

185077

1.47

307.65

4.0

3.8

0.00

estimate

0.58

6909

37970

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

45256

253256

1.88

307.65

4.5

4.3

10.08

11.47

mm/h

105.13

42962

238044

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

22722

118056

1.49

307.65

3.3

31.53

33.21

u/l

2.66

21564

111681

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

54498

316796

3.04

307.65

6.4

5.2

1.77

1.88

mu/l

36.62

52142

295928

(44816559) Phosphatidylethanol [Mass/volume] in Blood

4718

14486

2.31

307.65

1.9

1.7

0.29

0.31

mg/l

1.56

2368

6866

(3010813) Leukocytes [#/volume] in Blood

58432

377052

4.51

307.65

25.5

22.7

6.70

6.71

e9/l

0.37

57651

368445

(46235355) HIV 1 and 2 tests - Meaningful Use set

16184

77484

1.57

307.65

2.3

2.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

53568

334976

1.85

307.65

5.0

4.8

1.45

1.46

mmol/l

2.96

50918

314908

(3000963) Hemoglobin [Mass/volume] in Blood

58430

377086

4.49

307.65

25.7

22.8

136.07

135.84

g/l

3.83

58150

373604

(3020564) Creatinine [Moles/volume] in Serum or Plasma

57430

362863

3.30

307.65

20.2

19.0

73.84

75.96

umol/l

53.24

57053

358823

(3036481) Cortisol [Moles/volume] in Serum or Plasma

7768

32761

1.69

307.65

2.1

2.4

377.55

379.33

nmol/l

0.32

7188

30568

(3037467) Urinalysis macro (dipstick) panel - Urine

40703

236775

1.52

307.65

4.8

4.5

11.27

40.38

0.34

349

(3013650) Neutrophils [#/volume] in Blood by Automated count

35334

200201

1.48

307.65

8.6

10.0

4.03

4.10

e9/l

6.71

30744

174202

(3023103) Potassium [Moles/volume] in Serum or Plasma

55545

342726

2.54

307.65

18.5

17.4

3.94

3.96

mmol/l

39.43

54726

335292

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

51184

318196

1.64

307.65

4.3

4.1

1.31

1.28

mmol/l

9.70

48236

296924

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

45328

260142

1.76

307.65

7.8

8.3

75.34

78.60

u/l

51.41

43366

247629

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

47916

291894

1.57

307.65

19.7

18.3

13.45

13.54

49.75

47464

288050

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

15528

76417

1.51

307.65

1.8

0.91

1.22

mg/l

32.66

11737

58975

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

13716

65544

1.54

307.65

1.4

1.3

31.70

33.49

iu/ml

0.17

3858

19977

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

29876

156701

1.58

307.65

2.6

2.5

3032.18

76.39

nmol/l

0.50

27734

143732

(3019069) Monocytes/Leukocytes in Blood

29447

165273

1.41

307.65

6.4

6.9

8.59

8.77

23.92

27790

155791

(3013826) Glucose [Moles/volume] in Serum or Plasma

34666

200123

1.41

307.65

5.1

6.44

6.66

mmol/l

65.19

32912

188191

(3006504) Eosinophils/Leukocytes in Blood

29382

164826

1.41

307.65

6.3

6.8

2.85

2.83

0.55

27693

155274

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

21132

109164

1.48

307.65

2.9

2.7

58.54

67.71

u/l

0.95

19597

101496

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

51966

315744

1.92

307.65

6.1

6.0

38.00

38.86

mmol/mol

100.12

49577

297644

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

43334

242195

1.78

307.65

3.8

3.2

42.92

45.88

u/l

10.24

41415

229429

(3007461) Platelets [#/volume] in Blood

58415

376777

4.47

307.65

25.5

22.7

258.79

253.79

e9/l

67.86

57750

369328

(3019550) Sodium [Moles/volume] in Serum or Plasma

55447

342021

2.50

307.65

18.4

17.3

139.56

139.68

mmol/l

23.14

54683

335240

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

57286

361505

3.17

307.65

12.5

11.6

26.95

26.64

u/l

1.90

56268

352034

(3035941) MCH [Entitic mass]

58427

376942

4.51

307.65

25.4

22.5

30.28

30.23

10.34

58143

373395

(3023323) Follitropin [Units/volume] in Serum or Plasma

5465

19044

2.04

307.65

1.4

23.69

26.35

iu/l

7.17

4645

16220

(3001604) Monocytes [#/volume] in Blood

32376

179007

1.49

307.65

6.2

6.6

0.56

0.58

e9/l

28.63

28119

154925

(3031040) Bacteria [#/volume] in Urine by Automated count

39246

224845

1.53

307.65

5.1

4.5

1704.45

1695.89

e6/l

0.01

502

3059

(3048689) Calprotectin [Mass/mass] in Stool

11409

47667

1.77

307.65

2.4

2.6

106.44

135.04

ug/g

17.35

9094

38134

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

58427

376970

4.50

307.65

25.9

23.1

41.07

41.06

0.02

58133

373259

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

49497

268590

2.50

307.65

5.1

4.3

14.50

14.72

pmol/l

75.09

46791

247932

(3019198) Lymphocytes [#/volume] in Blood

33044

183424

1.49

307.65

6.3

6.6

1.97

1.92

e9/l

5.15

29288

162457

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

27065

149354

1.41

307.65

6.3

6.8

1.21

mmol/l

2.54

25316

138741

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

52797

322034

2.00

307.65

5.2

4.8

5.78

5.87

mmol/l

49.01

49798

299228

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

55697

342411

2.67

307.65

16.6

15.0

20.45

23.78

mg/l

114.22

46716

279163

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

54378

340752

1.96

307.65

5.7

5.4

2.76

2.75

mmol/l

1.67

51799

320642

(3009261) Glucose [Presence] in Urine by Test strip

33512

188681

1.46

307.65

4.0

3.8

0.51

0.19

estimate

0.61

6700

36769

(3015377) Calcium [Moles/volume] in Serum or Plasma

22602

114191

1.55

307.65

2.9

3.6

2.35

2.36

mmol/l

0.09

20766

104537

(3013115) Eosinophils [#/volume] in Blood

33372

184916

1.50

307.65

6.5

6.8

0.19

e9/l

0.01

29392

162461

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

30125

167343

1.44

307.65

6.6

7.4

1.21

mmol/l

1.54

26331

144906

(3024561) Albumin [Mass/volume] in Serum or Plasma

27323

150521

1.42

307.65

4.6

5.2

36.73

35.94

g/l

104.57

25700

141460

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

53321

324863

2.10

307.65

15.2

14.4

87.55

84.07

ml/min/173m2

268.45

49568

297227

(3044889) 12 lead EKG panel

40539

231937

1.58

307.65

4.0

3.8

40.53

3053.17

1.50

436

(3026361) Erythrocytes [#/volume] in Blood

58426

376990

4.49

307.65

25.4

22.6

4.52

e12/l

0.77

57637

368405

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

12607

60409

1.52

307.65

1.3

7.51

11.41

u/ml

9.96

5110

23878

(3001122) Ferritin [Mass/volume] in Serum or Plasma

34853

170005

1.94

307.65

3.5

3.1

97.06

118.41

ug/l

58.01

33128

159718

(3011288) Drugs identified in Urine by Screen method Nominal

4383

11586

2.68

307.65

3.3

2.9

—

(3018095) Leukocytes [#/volume] in Urine

23421

127721

1.40

298.48

4.2

3.9

70.62

92.03

e6/l

4.49

16234

88378

(3018418) pH of Serum or Plasma

18888

99866

1.41

284.04

3.9

4.4

7.40

0.49

13051

71254

(3021387) Prolactin [Units/volume] in Serum or Plasma

3958

14331

1.93

283.97

1.6

1.7

307.99

303.87

mu/l

0.22

3532

13062

(3001019) Free T4 and TSH panel - Serum or Plasma

4667

17915

1.83

279.68

1.7

1.6

—

(3021589) Normoblasts [#/volume] in Blood

27677

156229

1.37

279.32

11.0

11.3

0.00

e9/l

5.60

22426

127788

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

12847

63703

1.46

271.40

2.6

3.0

2.43

2.45

mmol/l

42.13

11501

57187

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

4305

16318

1.85

268.10

2.5

2.4

6078.69

6098.80

u/l

0.01

1552

6660

(40768797) Stomach Pathology biopsy report

9748

46084

1.51

258.76

1.3

1.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

19017

102026

1.38

255.33

2.3

2.2

211.23

208.18

u/l

0.11

18104

96668

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1035

2071

3.42

253.91

2.3

2.0

—

(3014051) Protein [Presence] in Urine by Test strip

19016

102180

1.38

252.06

2.9

0.10

0.07

0.30

167

2158

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

21991

120999

1.36

251.30

3.5

3.4

1.51

2.05

e6/l

0.59

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

22420

123830

1.36

249.51

3.8

3.6

76.76

56.04

ng/l

0.51

12999

81844

(3019832) Treponema pallidum Ab [Presence] in Serum

9375

44718

1.50

235.94

2.0

1.8

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

47461

295901

1.42

232.00

21.1

18.8

333.05

332.65

g/l

18.57

47274

294240

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

24942

141103

1.34

230.94

3.8

3.7

0.77

0.48

estimate

0.58

5743

31306

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4761

19421

1.71

229.98

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

2332

7563

2.13

224.62

1.5

1.3

—

(36304419) Bacteria [Presence] in Urine

16930

90657

1.37

222.35

3.3

3.2

47.92

142.78

estimate

0.53

374

(3037522) Nuclear Ab [Titer] in Serum

10324

50752

1.45

221.51

1.4

469.25

535.79

titre

3.07

1932

10632

(36660697) Celiac disease serology panel - Serum

6605

29564

1.57

220.99

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

20014

110105

1.35

220.26

3.5

3.4

53.59

79.31

e6/l

3.16

15073

83464

(42870588) Differential panel, method unspecified - Blood

21369

118888

1.34

217.21

6.1

6.7

5.32

5.35

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

7137

32640

1.54

216.93

2.8

2.6

36.05

49.91

u/l

2.92

6090

27732

(3009214) Lutropin [Units/volume] in Serum or Plasma

3189

11751

1.88

215.23

1.5

1.4

8.76

9.84

u/l

4.80

2543

9496

(40760892) CBC W Ordered Manual Differential panel - Blood

15383

81525

1.37

213.67

4.2

4.7

—

14.80

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

15782

84003

1.37

213.28

3.9

3.7

0.67

0.25

1.93

778

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

13033

67254

1.40

212.41

1.7

28508119.55

37309655.81

pmol/l

0.91

11204

56348

(3017143) Hepatitis C virus Ab [Presence] in Serum

9442

46033

1.46

210.17

1.8

1.7

—

(3030467) Casts [#/volume] in Urine by Automated count

17523

95085

1.35

208.08

3.4

3.3

0.32

0.41

e6/l

8.45

12609

69103

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

3197

11988

1.85

204.11

2.1

1.8

39.57

40.73

nmol/l

1.64

3149

11753

(3017446) Testosterone [Moles/volume] in Serum or Plasma

6493

29627

1.54

198.00

2.8

2.3

13.15

12.96

nmol/l

1.04

5922

27157

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

2915

10773

1.87

194.47

2.1

1.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

18538

102383

1.33

191.31

3.2

0.31

0.24

estimate

0.26

5690

30618

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

5820

26177

1.56

188.61

1.2

122.77

144.99

u/ml

4.29

2194

9920

(3033658) Prothrombin time (PT) actual/Normal

16077

87106

1.34

188.53

4.2

92.48

90.86

14.06

15645

85187

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

12639

66031

1.37

187.22

1.8

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

5185

22849

1.59

183.21

3.3

3.6

4.52

4.54

pmol/l

0.83

4648

20709

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

2458

8808

1.93

179.64

2.2

1.8

202.18

201.71

pmol/l

0.07

2347

8420

(3022948) Iron [Moles/volume] in Serum or Plasma

11309

58519

1.38

176.00

2.5

2.7

14.01

13.60

umol/l

0.60

10598

54664

(4198724) Urine methamphetamine measurement

769

1612

3.25

175.65

3.3

2.0

—

(3019150) Specific gravity of Urine by Refractometry

15225

82629

1.33

173.38

4.0

3.9

1.02

1.17

kg/l

2.31

9774

54300

(3019309) Folate [Moles/volume] in Red Blood Cells

10201

52081

1.39

171.55

1.8

1.7

1206.66

1154.51

nmol/l

6.18

7852

39803

(40758558) Short blood count panel - Blood

18588

104170

1.30

166.47

6.0

6.6

—

(3000492) Spirometry study

7425

36058

1.45

164.58

1.5

—

18.61

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

8099

40070

1.42

162.08

2.5

2.9

6.88

8.46

umol/l

10.47

6866

35073

(3004789) Transferrin [Mass/volume] in Serum or Plasma

10514

54413

1.37

161.53

2.4

2.6

2.41

2.35

g/l

22.21

9703

50341

(3025941) Bacteria identified in Stool by Culture

4445

19494

1.59

159.18

1.3

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

5257

23978

1.53

158.30

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

24561

143550

1.27

153.97

1.9

1.41

1.36

mmol/l

11.68

21322

122037

(3024666) Lithium [Moles/volume] in Serum or Plasma

817

1936

2.88

152.26

13.4

13.3

0.60

0.62

mmol/l

2.69

764

1783

(3000850) Epithelial cells [#/volume] in Urine

13836

75282

1.32

150.52

2.7

6.39

5.80

e6/l

3.45

12578

68486

(3022145) Colonoscopy Study observation

7894

39543

1.40

145.76

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

5237

24352

1.50

143.17

1.3

232.97

241.80

u/ml

0.12

4886

22706

(3029937) Albumin [Presence] in Urine by Test strip

17900

101369

1.28

141.84

4.2

4.0

0.00

estimate

0.66

6649

35207

(3020961) Endomysium IgA Ab [Titer] in Serum

4020

17677

1.58

141.65

1.1

137.01

193.06

titre

0.62

520

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

11180

59547

1.33

139.49

3.1

2.9

0.97

1.15

e6/l

2.33

5616

31255

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

11791

63328

1.32

138.70

4.1

3.8

272.23

488.51

ng/l

6.11

8139

47185

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1760

6152

1.96

137.74

1.6

1.5

0.36

0.41

nmol/l

1.63

1367

4780

(3012095) Magnesium [Moles/volume] in Serum or Plasma

10584

56425

1.33

129.88

3.1

3.7

0.82

mmol/l

1.48

9893

53282

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

10283

54629

1.33

129.19

3.2

3.1

3.39

3.11

e6/l

1.21

4684

26213

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

9487

50131

1.33

122.88

2.5

2.7

23.15

22.74

2.17

8829

46652

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

3127

13405

1.61

121.95

1.7

1.6

11.82

16.68

u/ml

5.07

762

3349

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

3997

18246

1.52

118.25

1.1

17.11

6.54

u/ml

0.49

226

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1401

4796

2.00

116.14

1.6

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

3041

13111

1.60

115.68

1.4

1.3

227.63

222.70

miu/ml

0.30

1397

6118

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

627

1502

2.84

114.68

2.4

2.0

167.17

118.95

umol/l

2.23

326

748

(3008898) HLA-B27 [Presence]

3029

13090

1.59

114.06

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

3950

18165

1.50

112.63

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

15712

89599

1.25

110.76

2.4

2.7

330.42

339.03

umol/l

22.92

14124

79965

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2401

9987

1.65

105.25

1.4

294.35

271.93

ug/g

3.98

1337

5775

(3009466) Valproate [Moles/volume] in Serum or Plasma

1368

4809

1.95

105.15

6.0

5.4

366.36

367.41

umol/l

0.09

1216

4228

(3042517) Benzodiazepines panel - Urine

266

371

4.86

103.75

2.8

3.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1290

4495

1.96

101.68

1.6

1.7

374.04

381.65

mu/l

0.17

1055

3655

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1514

5568

1.86

101.63

1.4

23.39

26.27

u/l

2.69

1230

4590

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2228

9188

1.66

100.88

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2238

9249

1.66

100.50

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

2236

9278

1.65

98.85

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2937

13022

1.55

98.70

1.6

1.7

3.64

4.35

mg/l

3.80

2310

9377

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4686

22888

1.42

97.14

1.3

42.97

51.99

au/ml

2.18

264

1408

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

5010

24788

1.40

96.44

2.4

19.58

21.03

au/ml

0.69

615

2852

(3009508) Creatinine [Moles/volume] in Urine

19822

117235

1.22

95.35

3.4

3.5

7.82

7.73

mmol/l

1.59

17170

100359

(3000494) Fungus identified in Specimen by Culture

7914

42132

1.31

94.50

1.5

—

(3026782) Osmolality of Urine

11501

64227

1.26

94.30

2.8

2.9

518.88

533.52

mosm/kgh2o

8.72

10008

56483

(3007853) Bacteria identified in Skin by Aerobe culture

7742

41298

1.31

90.77

1.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

26897

164330

1.20

89.58

2.7

2.8

—

estimate

—

(3032080) INR in Blood by Coagulation assay

24964

151727

1.19

87.18

12.6

13.6

1.18

1.23

inr

31.00

20662

126639

(3003458) Phosphate [Moles/volume] in Serum or Plasma

8227

44459

1.29

87.12

5.4

6.5

1.04

mmol/l

0.58

7633

41524

(3014111) Lactate [Moles/volume] in Serum or Plasma

5840

30229

1.34

84.07

7.5

8.2

1.34

1.33

mmol/l

0.23

5737

29665

(21494755) Public health laboratory ask at order entry panel

7113

37886

1.31

83.70

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

891

2916

2.08

83.35

1.7

1.5

1.40

1.28

promille

1.57

678

2347

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2226

9644

1.58

82.43

1.1

—

(3017732) Neutrophils [#/volume] in Blood

8160

44486

1.28

79.94

2.8

3.2

4.38

4.49

e9/l

0.59

7129

38801

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

2049

8768

1.60

79.88

1.1

1.99

2.25

u/ml

0.58

1064

4749

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

5128

26301

1.35

78.12

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

4039

19954

1.40

77.65

4.3

4.4

24.28

24.20

mmol/l

0.88

3978

19722

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2970

13967

1.46

74.83

1.2

1.3

0.72

0.87

u/ml

0.33

268

1062

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1728

7221

1.64

74.10

1.1

1.98

1.93

u/ml

0.07

853

3729

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

6126

32492

1.31

73.61

2.3

2.4

0.22

0.21

g/l

21.49

5699

30396

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1485

5976

1.70

73.49

1.1

4.96

u/ml

0.00

674

2767

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2716

12632

1.48

72.35

1.5

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1551

6351

1.67

71.93

1.1

4.10

4.17

u/ml

0.05

762

3269

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

2197

9786

1.54

71.92

1.1

5.07

5.75

eliau/ml

0.23

321

1264

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

7432

40594

1.27

70.87

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

7040

38220

1.28

70.49

1.9

1.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2139

9541

1.54

69.55

1.2

4.16

3.98

0.42

359

1381

(3003888) Timothy IgE Ab [Units/volume] in Serum

1786

7663

1.59

68.77

1.1

5.19

5.47

u/ml

0.30

963

4149

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

9768

55358

1.23

66.84

1.9

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1515

6303

1.64

66.07

1.1

17.75

15.51

au/ml

0.55

433

1689

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1706

7334

1.59

65.14

1.1

0.91

1.12

u/ml

0.71

725

3338

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2766

13222

1.43

63.70

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1317

5339

1.68

63.42

1.1

0.49

0.40

u/ml

0.27

380

1690

(3003740) Influenza virus B Ag [Presence] in Specimen

1680

7292

1.57

61.57

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2001

9032

1.52

61.52

1.4

477.72

547.32

mg/l

4.86

1917

8665

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2497

11800

1.45

61.10

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1679

7300

1.57

61.09

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1807

8018

1.54

60.10

1.4

1.5

1019.34

2182.48

e6/l

1.02

1399

6312

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4713

24808

1.31

59.13

1.6

1.7

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1784

7925

1.54

59.02

1.4

35.37

32.18

e6/l

0.12

1295

5869

(3048929) Epstein Barr virus Ab [Presence] in Serum

2760

13369

1.42

59.00

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1791

8018

1.53

57.18

1.3

3.70

3.72

mmol/l

0.50

1698

7595

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

14364

85489

1.18

56.78

2.3

2.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

7320

40879

1.24

56.44

1.7

—

6.44

—

(3045414) Leukocytes [Presence] in Urine

6034

33002

1.26

55.84

2.1

0.02

0.03

estimate

0.92

1361

6812

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

2142

10057

1.46

54.15

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2130

10022

1.45

53.24

1.3

—

(3042936) Bacteria identified in Isolate by Culture

8531

48815

1.21

51.48

2.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1232

5196

1.62

50.91

1.1

2.92

3.00

eliau/ml

0.08

630

2476

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

7731

43871

1.22

50.66

1.9

3.48

3.51

ratio

0.89

5672

33296

(40761536) Microorganisms panel - Urine sediment

5145

27950

1.27

50.06

3.9

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3735

19546

1.31

48.51

1.8

1.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1106

4639

1.62

46.75

1.3

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

631

2250

1.91

46.68

1.3

5.29

5.25

umol/l

0.08

555

2010

(3005719) IgG [Mass/volume] in Serum or Plasma

5084

27832

1.26

46.16

2.5

2.9

10.46

10.60

g/l

1.45

4650

25826

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

660

2411

1.86

45.38

1.7

1.4

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

418

1302

2.18

44.56

2.4

2.6

138.29

151.25

nmol/l

1.79

379

1138

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

5890

32944

1.23

43.92

1.7

1.6

3.45

3.49

mmol/l

1.67

3920

22191

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

768

2972

1.76

43.78

2.1

2.4

20.32

19.44

nmol/l

1.42

722

2830

(3038177) Helicobacter pylori Ab [Presence] in Serum

1344

6006

1.52

43.28

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1212

5294

1.56

43.25

1.4

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

2091

10198

1.40

42.82

2.0

4.98

18.09

iu/l

1.60

858

4233

(3024354) Oxygen [Partial pressure] in Venous blood

5104

28254

1.24

41.78

3.6

3.5

4.64

4.60

kpa

0.56

4952

27529

(3021447) Carbon dioxide [Partial pressure] in Venous blood

6025

33959

1.22

41.57

4.1

5.88

5.82

kpa

4.82

5867

33150

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

15243

92955

1.15

40.80

3.1

3.2

1085.14

1290.26

ng/l

6.78

12673

79427

(3023368) Bacteria identified in Blood by Culture

15019

91575

1.15

40.15

4.4

4.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

1895

9190

1.41

40.09

1.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

4211

22914

1.26

40.01

8.2

8.6

24.88

24.76

mmol/l

1.29

4182

22744

(3025130) Human papilloma virus identified in Specimen

1333

6080

1.49

38.98

1.8

—

(3002032) Base excess in Venous blood by calculation

5847

33089

1.22

38.57

4.1

4.2

1.72

1.76

mmol/l

0.42

5191

29110

(3028026) IgM [Mass/volume] in Serum or Plasma

3972

21581

1.26

38.16

1.8

2.0

1.31

1.29

g/l

0.14

3669

19947

(3012544) pH of Venous blood

6050

34396

1.21

38.03

4.1

4.2

7.38

1.56

3222

19917

(3018677) aPTT in Platelet poor plasma by Coagulation assay

8731

51305

1.18

37.88

2.1

2.2

29.44

29.57

1.25

8498

49945

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1151

5123

1.53

37.79

1.1

2.58

2.83

0.44

228

853

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

4855

27034

1.23

37.44

2.7

72.34

67.64

ml/min/173m2

13.29

2146

11115

(3016650) Hepatitis A virus Ab [Presence] in Serum

1370

6345

1.47

37.15

1.1

—

(3022621) pH of Urine by Test strip

5015

28044

1.23

37.13

2.5

6.13

6.09

2.64

3079

18376

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

6431

36860

1.20

37.05

6.4

6.6

—

(3024928) Oxygen saturation in Venous blood

1741

8444

1.41

36.81

3.5

61.46

62.86

1.80

1667

8175

(3027945) Reticulocytes/Erythrocytes in Blood

6537

37655

1.20

35.55

2.5

2.7

1.78

1.77

0.42

5826

33767

(3007463) Buprenorphine [Presence] in Urine

129

4.78

35.18

9.0

7.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

627

2447

1.74

34.83

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

621

2422

1.74

34.58

1.2

—

(3008295) Osmolality of Serum or Plasma

829

3499

1.61

34.29

1.7

1.4

279.31

279.36

mosm/kgh2o

0.02

607

2719

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

483

1757

1.87

33.81

1.4

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1346

6332

1.45

33.69

1.1

—

(3023410) Appearance of Cerebral spinal fluid

844

3599

1.59

33.48

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

639

2539

1.71

33.33

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3604

19672

1.25

33.16

9.4

10.3

24.33

24.26

mmol/l

0.66

3516

19263

(3023420) DNA double strand Ab [Units/volume] in Serum

2899

15419

1.29

33.04

1.8

1.9

6.85

7.93

iu/ml

0.80

681

3593

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2170

11097

1.33

32.96

1.3

26.28

40.05

u/ml

1.51

103

603

(3045424) Erythrocytes [Presence] in Urine

3154

16969

1.27

32.78

2.0

2.1

0.03

0.13

estimate

0.87

1169

5386

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1682

8291

1.38

32.34

1.2

1.3

37.25

46.33

u/ml

1.16

137

769

(3003181) Sodium [Moles/volume] in Urine

1255

5883

1.45

32.02

1.5

1.4

60.31

62.30

mmol/l

0.89

985

4661

(3002256) Pathology report gross observation

7756

45714

1.17

31.86

1.3

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

513

1939

1.80

31.82

1.7

1.5

1916763.02

1949720.91

iu/ml

0.02

132

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

1117

5129

1.48

31.68

2.5

13.11

13.16

0.95

1106

5066

(3013512) EKG study

17723

110458

1.12

31.61

3.5

0.68

0.76

0.41

249

(3007566) Smooth muscle Ab [Titer] in Serum

2052

10480

1.34

31.44

1.2

1.3

93.72

120.26

titre

1.45

199

1020

(3014007) Fractional oxyhemoglobin in Arterial blood

3918

21728

1.23

31.18

9.6

10.5

93.85

94.03

0.94

3900

21665

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3905

21649

1.23

31.17

9.5

10.4

1.39

1.32

4.12

3891

21521

(44813793) Dust mix specific IgE antibody measurement

648

2633

1.67

31.16

1.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

847

3683

1.56

30.96

1.2

44.33

28.00

nmol/l

1.37

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1283

6080

1.44

30.91

1.3

1.4

3.34

3.65

ug/l

0.76

1178

5461

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

4538

25586

1.22

30.73

3.7

4.1

82.99

89.28

ng/l

4.66

3979

22329

(3013005) Retinol [Moles/volume] in Serum or Plasma

447

1638

1.85

30.65

1.6

2.1

1.96

1.94

umol/l

0.19

406

1499

(3019977) pH of Arterial blood

6575

38415

1.18

29.97

7.7

8.2

7.42

0.66

3405

20865

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

654

2711

1.64

29.16

1.1

6.55

8.31

iu/ml

1.13

183

733

(3016244) Insulin [Units/volume] in Serum or Plasma

601

2444

1.67

28.86

2.7

3.2

27.28

25.88

mu/l

0.36

559

2302

(3034770) Mitochondria Ab [Titer] in Serum

1997

10287

1.32

28.84

1.2

1.3

781.04

951.53

titre

0.47

281

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1330

6433

1.41

28.62

1.3

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3773

21031

1.23

28.54

9.8

10.7

0.63

0.64

0.59

3761

20923

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1329

6432

1.41

28.51

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2290

12053

1.30

28.27

2.0

2.4

413.65

550.53

ug/l

1.78

2133

11371

(3027801) Oxygen [Partial pressure] in Arterial blood

6539

38364

1.17

28.19

7.6

8.1

12.46

12.68

kpa

2.70

6317

36931

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

6541

38381

1.17

28.15

7.6

8.1

5.11

5.08

kpa

1.51

6323

36959

(3003694) ABO and Rh group [Type] in Blood

17149

107223

1.11

28.03

1.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2154

11261

1.30

27.97

1.8

0.23

g/l

0.62

2074

10742

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

146

344

2.87

27.96

1.3

1.4

2.05

2.38

mmol/l

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2207

11578

1.30

27.93

1.8

1.19

g/l

0.18

2127

11086

(4034850) Laboratory test

1930

9970

1.32

27.33

9.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1456

7224

1.37

26.95

2.6

2.8

32.31

34.05

umol/l

2.00

1308

6555

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

160

407

2.66

26.66

1.2

—

(3003396) Base excess in Arterial blood by calculation

6467

38128

1.16

26.06

7.6

8.1

0.81

0.92

mmol/l

1.42

5452

31477

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1988

10412

1.30

25.48

1.3

8.42

8.85

u/ml

0.10

265

1488

(3034274) Bile acid [Moles/volume] in Serum --fasting

1191

5772

1.40

25.39

1.9

2.3

5.71

7.00

umol/l

1.74

874

4241

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

4529

25985

1.19

25.30

3.5

4.0

1.23

mmol/l

1.16

3916

22474

(3052851) Hemolysis interference index of Serum or Plasma

1794

9284

1.32

25.10

2.9

3.2

2.29

2.23

index

0.09

927

4715

(3030981) Hyaline casts [#/volume] in Urine by Automated count

4757

27446

1.19

24.93

2.4

2.5

0.37

0.40

e6/l

0.48

4509

26212

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

369

1364

1.83

24.74

1.4

73.65

73.17

0.26

345

1307

(1761482) Bacteria [#/volume] in Urine by Culture

772

7694

0.67

24.72

4.0

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

443

1731

1.74

24.69

1.4

1.2

261.97

332.44

u/l

0.94

411

1621

(3024980) IgG subclass 4 [Mass/volume] in Serum

1261

6210

1.38

24.47

1.5

1.6

0.70

0.77

g/l

2.08

986

4849

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1983

10439

1.29

24.46

1.3

3.57

6.80

u/ml

2.16

157

983

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1052

5022

1.42

24.45

1.3

0.21

0.25

nmol/l

0.34

310

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

3907

22188

1.20

24.38

1.5

1.6

1029.47

1012.37

mu/l

0.45

3282

18898

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1039

4956

1.42

24.25

1.3

0.60

1.73

nmol/l

1.58

1007

4787

(3016502) Oxygen saturation in Arterial blood

5809

34146

1.17

24.23

7.9

8.5

95.69

95.73

0.18

5661

32953

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

332

1195

1.88

24.19

1.4

13.94

14.93

pmol/l

2.65

280

1011

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

362

1345

1.82

23.90

1.4

532.84

668.74

mu/l

0.73

338

1288

(3020891) Body temperature

2744

15071

1.24

23.78

4.6

4.7

36.93

36.91

°c

1.61

2717

14937

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3138

17485

1.23

23.75

3.4

3.1

1.39

1.26

7.67

3128

17409

(3015076) Soybean IgE Ab [Units/volume] in Serum

544

2279

1.62

23.38

1.0

1.1

0.55

0.88

u/ml

0.54

118

598

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

617

2667

1.57

23.29

1.5

1.3

227.42

176.32

pmol/l

0.60

617

2667

(3014599) Egg white IgE Ab [Units/volume] in Serum

582

2487

1.59

23.07

1.0

1.1

7.38

2.40

u/ml

0.47

145

658

(3029634) Reagin Ab [Titer] in Serum by VDRL

1148

5626

1.39

22.97

2.5

2.2

8.58

8.14

titre

0.04

161

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

614

2662

1.57

22.89

1.1

17.97

19.34

u/ml

0.42

288

1048

(3025159) Blasts/Leukocytes in Blood

5194

30397

1.17

22.84

4.4

4.8

0.18

0.28

0.65

1114

7807

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

948

4497

1.43

22.84

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

232

751

2.09

22.78

2.2

2.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3104

17351

1.22

22.76

3.4

3.1

0.61

0.62

2.47

3097

17300

(3035637) Corticotropin [Mass/volume] in Plasma

979

4692

1.42

22.30

1.5

1.6

27.23

33.81

ng/l

2.22

974

4682

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

984

4732

1.41

22.00

2.0

1.9

3429.57

3882.67

titre

0.12

195

(3019420) Tryptase [Mass/volume] in Serum or Plasma

508

2127

1.62

21.93

1.4

1.6

6.62

8.81

ug/l

2.51

470

1946

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1811

9562

1.29

21.86

2.1

2.3

0.03

0.02

g/l

0.13

1613

8646

(3020717) Zinc [Moles/volume] in Serum or Plasma

490

2037

1.63

21.77

1.5

1.6

23.15

22.94

umol/l

0.05

455

1899

(3036180) Methadone [Presence] in Urine

5.35

21.47

2.1

3.8

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

325

1212

1.82

21.28

2.2

2.6

1.12

1.10

ug/l

0.06

305

1149

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

823

3859

1.45

21.14

1.1

22.50

22.46

au/ml

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

2757

15341

1.23

21.14

1.1

1.52

1.51

g/l

0.46

2751

15332

(44806420) Estimation of glomerular filtration rate

839

3953

1.44

21.01

2.5

2.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3866

22229

1.19

20.97

3.5

3.8

5.14

kpa

0.02

3712

21211

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1731

9141

1.29

20.88

2.1

2.3

0.00

g/l

0.15

1500

8045

(3009343) pH of Capillary blood

3761

21601

1.19

20.66

3.5

3.8

7.41

7.42

3.01

3161

17955

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1500

7795

1.31

20.43

1.3

244.05

257.56

u/ml

1.19

960

4959

(3036489) Thrombin time

2518

13936

1.23

20.33

2.1

2.2

20.46

21.05

5.86

2188

12283

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

801

3767

1.44

20.28

1.1

87.57

70.36

au/ml

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

12736

93057

0.90

20.11

5.1

2.10

2.85

ug/l

4.50

11682

84902

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

418

1707

1.66

19.95

1.6

1.7

15.44

5.48

nmol/l

0.36

342

1414

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

5495

32618

1.15

19.92

3.4

3.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

359

1408

1.73

19.88

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3319

18920

1.20

19.82

3.4

3.7

1.59

1.71

mmol/l

1.38

2409

13847

(3045683) HLA typing for celiac disease panel - Blood or Tissue

511

2199

1.58

19.75

1.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

5417

32146

1.15

19.70

8.4

9.0

123.14

121.39

g/l

8.13

5325

31394

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4401

25720

1.17

19.60

2.5

2.3

5.93

7.57

ug/l

6.60

3814

22619

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2723

15255

1.22

19.52

2.1

40.72

39.71

u/l

1.78

2448

13746

(3028192) IgG subclass 2 [Mass/volume] in Serum

809

3843

1.43

19.43

1.3

1.4

3.00

2.93

g/l

0.46

585

2784

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

2604

14533

1.22

19.39

1.1

0.65

0.63

ratio

0.68

251

1684

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

886

4280

1.41

19.37

1.3

0.21

0.26

nmol/l

0.42

683

3341

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1578

8317

1.29

19.35

1.2

1.3

45.40

43.56

u/ml

0.08

133

(3002079) Sodium [Moles/time] in 24 hour Urine

403

1646

1.66

19.25

1.3

1.2

158.10

160.98

mmol/24h

0.27

403

1646

(3017509) Phencyclidine [Presence] in Urine

150

436

2.33

19.16

2.4

1.6

—

(3020874) Milk IgE Ab [Units/volume] in Serum

582

2598

1.52

19.13

1.1

2.34

1.71

u/ml

0.21

179

875

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

477

2037

1.59

19.07

1.1

5.14

5.83

nmol/l

0.11

377

(3023520) Reticulocytes [#/volume] in Blood

4891

28878

1.16

19.04

2.5

2.7

70.91

69.84

e9/l

1.09

3407

21208

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1614

8554

1.28

18.96

2.2

2.4

0.00

g/l

-0.00

1499

8025

(3024139) IgG subclass 3 [Mass/volume] in Serum

806

3844

1.42

18.95

1.3

1.4

0.37

0.41

g/l

1.83

584

2786

(4062490) Immunoglobulin typing, IgG

794

3777

1.43

18.94

1.4

—

(40768443) Skin Pathology biopsy report

2791

15732

1.21

18.80

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

806

3850

1.42

18.80

1.3

1.4

6.49

6.76

g/l

1.26

585

2787

(43055514) Macroprolactin [Presence] in Serum or Plasma

276

1018

1.84

18.79

1.4

—

(4024509) Urine culture

2745

15454

1.21

18.72

2.0

1.9

—

(3019225) pH of Specimen

5156

30602

1.15

18.67

3.8

4.2

7.36

0.01

3625

22106

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

158

479

2.23

18.35

1.0

86.35

81.11

ug/l

0.70

126

376

(1616796) Gas panel - Central venous blood

1439

7555

1.29

18.20

3.2

3.8

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

2803

15862

1.20

18.12

1.1

1.2

0.89

g/l

0.10

2793

15820

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

664

3081

1.46

18.10

1.2

36.78

44.70

mg/l

3.32

552

2620

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

186

608

2.07

17.94

1.7

1.6

1.38

1.14

nmol/l

—

(3038515) Glucose [Moles/volume] in Venous blood

691

6617

0.70

17.88

3.2

3.3

7.10

7.51

mmol/l

3.06

662

6478

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

284

1074

1.79

17.87

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

376

1542

1.65

17.73

1.6

2.1

28.87

28.50

umol/l

0.29

344

1452

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1361

7119

1.30

17.72

1.8

1.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

284

1080

1.78

17.56

1.2

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

5.31

17.44

1.8

1.1

2.09

2.05

g/l

0.07

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1630

8751

1.27

17.28

1.3

5.40

5.09

u/ml

0.04

585

(3001556) Androgen free Index in Serum or Plasma

130

373

2.36

17.15

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2035

11228

1.23

16.95

2.2

2.5

0.65

0.76

g/l

0.83

1760

9709

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

632

2951

1.45

16.73

1.2

114.45

111.03

pmol/l

0.66

632

2951

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

614

2854

1.46

16.64

1.2

1.3

2.44

2.14

u/ml

0.22

346

1678

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

725

3478

1.41

16.58

1.4

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1291

6769

1.30

16.54

2.8

3.5

7.68

9.26

pmol/l

7.08

1291

6762

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

637

2986

1.45

16.52

1.1

249.31

270.83

mg/l

1.08

561

2663

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

317

1269

1.69

16.42

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

308

1230

1.70

16.11

1.2

109.67

110.67

0.26

279

1110

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

400

1714

1.58

15.87

1.8

2.14

3.02

u/ml

0.69

112

495

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

153

490

2.11

15.63

1.0

9.68

8.83

u/ml

0.12

153

490

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

631

2987

1.43

15.57

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

399

1719

1.57

15.49

1.2

8.69

9.93

mm/h

1.66

399

1719

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

257

989

1.76

15.35

1.4

1.3

120.51

132.57

nmol/l

0.42

195

718

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

599

2822

1.44

15.18

1.1

—

(3002179) Metamyelocytes/Leukocytes in Blood

4997

30010

1.14

15.12

3.9

4.4

0.69

0.70

0.13

1288

9003

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

144

457

2.13

15.07

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

455

2033

1.52

15.03

1.5

6.00

6.06

u/l

0.04

398

1732

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1974

10998

1.22

15.01

2.5

2.7

179.01

189.40

6.04

1862

10489

(4027681) Cerebrospinal fluid IgG ratio and IgG index

508

2328

1.48

14.86

1.3

1.2

0.68

0.65

ratio

0.09

287

1342

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

3247

18936

1.17

14.81

2.5

3.5

38.96

54.89

u/ml

2.31

3140

18316

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

253

2.54

14.72

1.2

44.93

48.57

mg/l

0.41

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2190

12362

1.21

14.58

2.1

2.4

2.85

2.89

g/l

1.21

1985

11269

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

319

1326

1.63

14.40

1.2

0.30

g/l

0.19

261

1060

(3012501) Base excess in Blood by calculation

1293

6906

1.27

14.38

3.7

3.9

2.33

2.50

mmol/l

1.44

864

4637

(3041806) Other cells [#/volume] in Blood by Manual count

367

1579

1.57

14.38

1.6

1.4

0.51

0.52

e9/l

0.53

367

1579

(3013290) Carbon dioxide [Partial pressure] in Blood

1293

6908

1.27

14.35

3.7

4.0

5.02

5.00

kpa

0.56

1265

6746

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

210

777

1.83

14.31

1.1

27.89

29.63

iu/ml

0.18

210

777

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1649

9080

1.23

14.06

1.3

30.23

14.16

u/ml

0.53

108

(3027315) Oxygen [Partial pressure] in Blood

1296

6953

1.27

13.91

3.7

4.0

8.88

8.71

kpa

3.00

1268

6790

(3050129) First trimester maternal screen panel - Serum or Plasma

2531

14560

1.18

13.66

1.4

1.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1060

5561

1.29

13.61

1.1

118.87

117.47

0.77

956

5091

(3020911) Cortisol [Moles/time] in 24 hour Urine

306

1278

1.62

13.59

1.5

1.4

180.40

185.03

nmol/24h

0.02

306

1278

(3021440) Promyelocytes/Leukocytes in Blood

4991

30190

1.13

13.44

4.2

4.7

0.13

0.12

0.40

1111

8152

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1915

10760

1.21

13.40

1.6

—

(3010421) pH of Blood

1874

10509

1.21

13.38

3.5

3.6

7.41

0.33

1846

10359

(3011985) Renin [Units/volume] in Plasma

1000

5224

1.30

13.27

1.6

69.71

64.14

mu/l

0.27

912

4720

(3016038) Potassium [Moles/volume] in Urine

474

2196

1.46

13.19

1.3

31.88

34.09

mmol/l

1.31

414

1932

(3028626) Oxygen [Partial pressure] in Capillary blood

1605

8878

1.23

13.14

3.6

3.7

8.61

8.43

kpa

3.96

1572

8656

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

3.96

12.94

1.8

1.5

223.10

281.96

nmol/l

0.27

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

426

1941

1.49

12.90

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

587

2845

1.40

12.79

1.2

1.3

1.90

2.13

mmol/l

5.37

539

2642

(3017181) Myelocytes/Leukocytes in Blood

5188

31548

1.12

12.77

4.1

4.6

0.98

0.94

0.39

1305

9476

(3005082) Progesterone [Moles/volume] in Serum or Plasma

507

2399

1.43

12.65

1.4

1.5

34.36

34.13

nmol/l

0.05

456

2225

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2097

11960

1.19

12.52

3.7

4.1

24.67

24.79

mmol/l

1.32

1977

11053

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2050

11670

1.19

12.50

2.7

3.0

24.57

24.68

mmol/l

0.71

2011

11456

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

151

527

1.94

12.36

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

133

444

2.03

12.32

1.2

61.89

63.86

ug/l

0.55

133

444

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

920

4805

1.30

12.28

1.4

344.28

371.08

pmol/l

0.37

810

4140

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1143

6140

1.26

12.20

1.3

4.36

3.55

u/ml

0.50

449

2360

(3018405) Lactate [Moles/volume] in Arterial blood

1818

10261

1.20

12.17

4.0

4.2

1.38

mmol/l

0.04

1796

10061

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2085

11919

1.19

12.14

2.4

2.5

96.10

93.56

5.95

1986

11497

(3010838) Calcium [Moles/time] in 24 hour Urine

1175

6346

1.26

11.99

1.9

5.26

5.16

mmol/24h

0.47

1048

5720

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

10226

73998

0.92

11.98

4.2

21.76

22.02

0.81

4142

33837

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

170

624

1.84

11.98

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

609

3006

1.37

11.94

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1108

5961

1.26

11.70

1.3

4.62

3.89

u/ml

0.51

515

2840

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1719

9692

1.21

11.66

2.0

2.2

10.96

11.40

mg/l

1.61

1600

9122

(3022806) Fractional oxyhemoglobin in Capillary blood

766

3934

1.32

11.58

1.9

1.8

90.15

90.09

0.10

756

3869

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

257

1072

1.62

11.56

1.2

1.3

14.06

22.22

0.95

188

(4195642) Thrombophilia screening test

1035

5532

1.27

11.55

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

838

4368

1.30

11.39

1.3

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

525

2550

1.40

11.37

1.1

—

0.25

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

430

2016

1.45

11.34

1.0

264.09

347.18

ng/l

3.87

326

1480

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

431

2028

1.44

11.16

1.0

33.18

42.33

ng/l

5.24

323

1458

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1076

5805

1.26

11.12

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

429

2025

1.44

10.93

1.0

838.47

746.02

ng/l

3.14

304

1442

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1240

6811

1.24

10.93

1.7

1.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

292

1274

1.55

10.92

1.0

0.39

0.66

u/ml

1.37

285

1250

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

156

2.69

10.85

1.4

1.5

441.84

537.20

nmol/l

0.73

156

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

163

612

1.80

10.75

1.6

0.20

0.23

nmol/l

0.48

115

453

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

850

4475

1.29

10.74

1.3

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

834

4382

1.29

10.71

1.3

1.4

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

377

1746

1.46

10.63

1.2

1.3

71.70

63.95

0.62

219

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

393

1835

1.45

10.63

2.0

1.9

138.50

147.11

1.47

373

1740

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2203

12802

1.17

10.58

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1956

11275

1.18

10.38

2.1

2.3

9.94

10.16

g/l

1.50

1728

10082

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1735

9903

1.19

10.34

1.3

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

286

1259

1.54

10.31

1.2

113.19

107.71

1.40

257

1155

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1474

8296

1.21

10.24

1.4

1.5

59.47

60.19

ug/l

0.25

1474

8296

(3043409) Potassium [Moles/volume] in Arterial blood

1526

8617

1.20

10.24

4.3

4.5

3.84

3.87

mmol/l

2.44

1520

8545

(3045716) Anion gap in Serum or Plasma by calculation

685

3529

1.32

10.20

2.8

3.1

10.26

10.82

mmol/l

3.48

676

3484

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

375

1753

1.45

10.11

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

793

4177

1.29

10.02

1.3

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2242

13108

1.16

9.98

2.1

2.3

7.25

7.37

g/l

2.84

2038

12013

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2239

13090

1.16

9.97

2.1

2.3

4.23

4.22

g/l

0.15

2036

12009

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

184

2.46

9.91

1.3

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

791

4172

1.29

9.90

1.3

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2234

13070

1.16

9.86

2.1

2.3

3.72

3.71

g/l

0.13

2032

11985

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

960

5190

1.25

9.81

1.2

14.67

17.86

u/ml

0.23

218

(3028271) Lactate [Moles/volume] in Capillary blood

955

5161

1.26

9.79

2.0

1.8

1.73

mmol/l

0.02

930

5021

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

813

6952

0.79

9.78

2.7

3.6

586.84

883.30

u/ml

0.60

722

6307

(3020650) Glucose [Presence] in Urine

280

1243

1.53

9.75

1.6

0.02

0.05

estimate

0.90

280

1243

(3025468) Yersinia sp identified in Specimen by Organism specific culture

787

4164

1.28

9.63

1.3

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1433

8096

1.20

9.59

1.4

87.10

141.06

pmol/l

6.54

1391

7897

(3020630) Protein [Mass/volume] in Serum or Plasma

4435

27165

1.11

9.56

2.2

2.7

66.68

66.44

g/l

1.39

4057

25043

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

3.12

9.54

1.7

1.5

191.31

238.43

nmol/l

0.29

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

276

1228

1.52

9.52

1.1

95.32

90.10

1.86

120

588

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

339

1574

1.46

9.50

1.9

2.6

20.86

197.29

ug/l

1.84

324

1504

(3001186) Copper [Moles/volume] in Serum or Plasma

233

1000

1.58

9.43

1.2

1.4

16.40

16.56

umol/l

0.20

198

867

(3028679) Herpes simplex virus Ab [Presence] in Serum

455

2233

1.38

9.37

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

626

3229

1.31

9.29

4.4

5.4

108.13

104.73

u/ml

0.04

175

1141

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

270

1205

1.52

9.20

1.1

99.96

90.08

3.08

119

585

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

104

355

1.98

9.20

1.2

2.08

1.68

iu/ml

1.47

184

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

798

4255

1.27

9.20

1.1

99.67

96.49

2.67

737

4022

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

740

3911

1.28

9.16

2.0

25.32

25.27

mg/l

0.01

276

1455

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2507

14897

1.14

8.94

1.5

1.6

9.51

14.67

iu/ml

1.34

420

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1992

11657

1.16

8.81

1.4

1.5

1.21

1.18

ratio

0.61

1143

7107

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1986

11622

1.16

8.78

1.4

1.5

1.17

ratio

0.07

1135

7003

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1991

11657

1.16

8.75

1.4

1.5

0.98

0.94

ratio

2.39

1140

7040

(3027231) Wheat IgE Ab [Units/volume] in Serum

196

823

1.61

8.73

1.1

4.32

2.62

u/ml

0.21

165

718

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

473

2365

1.35

8.71

16.1

15.8

766.76

2022.50

nmol/l

1.08

461

2288

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

2092

12305

1.15

8.64

1.5

62.29

62.52

ug/l

0.08

1719

10321

(3004616) Nuclear Ab [Presence] in Serum

835

4512

1.25

8.64

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

120

441

1.84

8.58

1.8

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

1252

7063

1.20

8.57

2.6

17.07

16.62

5.82

1218

6911

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

192

808

1.61

8.49

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

494

2499

1.34

8.45

21.0

21.3

1322.76

2694.89

nmol/l

1.11

480

2408

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

368

1776

1.40

8.43

1.5

1.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1951

11439

1.16

8.42

1.4

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1682

9750

1.17

8.42

1.5

1.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

297

1379

1.46

8.39

1.9

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1463

8386

1.18

8.39

2.1

2.3

133.26

130.44

g/l

4.34

1126

6533

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2096

12366

1.15

8.31

1.6

8.30

5.60

iu/ml

0.13

368

2236

(3039162) Centromere protein B Ab [Units/volume] in Serum

861

4691

1.24

8.30

1.2

1.3

52.59

53.37

u/ml

0.03

276

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

752

4035

1.26

8.28

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2567

15363

1.14

8.24

1.8

1.47

1.52

g/l

1.47

2211

13259

(3008037) Lactate [Moles/volume] in Venous blood

963

7917

0.82

8.13

3.0

3.1

1.51

1.55

mmol/l

0.54

926

7741

(3004119) Hemoglobin [Mass/volume] in Venous blood

3400

20732

1.12

7.98

3.4

3.5

131.90

129.58

g/l

7.72

3306

20163

(3010015) Selenium [Moles/volume] in Serum or Plasma

104

375

1.88

7.92

1.9

2.1

1.28

1.32

umol/l

0.42

278

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

295

2.00

7.91

1.6

2.36

2.66

mg/l

0.15

210

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

295

2.00

7.91

1.6

2.53

1.93

mg/l

0.38

190

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

295

2.00

7.91

1.6

2.04

2.61

mg/l

0.53

206

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

295

2.00

7.91

1.6

1.34

1.31

mg/l

0.02

176

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

295

2.00

7.91

1.6

4.42

3.92

mg/l

0.26

184

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

295

2.00

7.91

1.6

2.18

2.19

mg/l

0.00

217

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

295

2.00

7.91

1.6

0.73

0.88

mg/l

0.24

197

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

296

1.99

7.84

1.6

2.24

1.60

mg/l

0.45

181

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

296

1.99

7.84

1.6

1.61

1.88

mg/l

0.26

216

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

454

2297

1.34

7.80

1.2

1.1

1.06

ratio

0.31

378

1924

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1305

7457

1.19

7.79

1.4

1.5

143.26

147.58

au/ml

0.62

354

2123

(3020779) Urea [Moles/volume] in Serum or Plasma

4859

30205

1.10

7.78

6.6

8.2

8.42

9.62

mmol/l

29.26

4662

28915

(3004775) Volume in Urine collected for unspecified duration

250

2455

0.69

7.78

2.0

2.4

678.15

672.20

0.08

172

1721

(4268621) Lupus anticoagulant assay

791

4309

1.24

7.68

2.4

2.3

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

106

389

1.84

7.67

1.0

1.1

1.21

2.80

u/ml

0.82

304

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

304

1.96

7.62

1.6

1.69

1.66

mg/l

0.02

195

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

559

2925

1.29

7.57

1.1

294.90

387.50

mg/l

0.45

517

2672

(40768800) Prostate Pathology biopsy report

637

5429

0.79

7.57

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

175

742

1.60

7.57

1.1

2.88

7.73

u/ml

1.18

102

500

(3021901) Oxygen saturation in Capillary blood

1227

6995

1.19

7.54

2.8

3.1

91.25

90.48

5.16

1196

6807

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1641

9582

1.16

7.53

1.5

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

152

624

1.65

7.48

1.4

1.6

5.17

5.67

nmol/l

1.01

141

601

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

494

2548

1.31

7.45

1.1

1.2

1.15

2.02

0.43

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

6257

39393

1.08

7.45

3.7

4.6

228.28

243.21

u/l

16.22

5911

37545

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

288

1.97

7.44

1.2

0.52

0.55

iu/ml

0.09

141

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1406

8120

1.17

7.43

1.4

1.5

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

2.96

7.37

1.2

1.8

608.88

1730.36

umol/l

—

(3051101) Glucose [Moles/volume] in Cord blood

519

0.35

7.36

5.9

5.5

8.29

8.52

mmol/l

0.21

519

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

115

439

1.77

7.35

1.4

1.3

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

459

2352

1.32

7.27

2.8

3.5

81.27

154.75

nmol/l

6.26

449

2310

(3005033) Fetal Nuchal fold Thickness US

1605

9388

1.16

7.22

1.4

1.5

1.28

1.25

1.31

1157

6896

(40757494) Bilirubin.total [Moles/volume] in Blood

319

1550

1.39

7.11

1.9

2.2

19.47

35.78

umol/l

1.91

152

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

430

2191

1.33

7.09

2.1

2.0

173.96

907.81

pmol/l

1.37

320

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.80

6.91

1.1

—

mmol/l

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

280

1338

1.42

6.89

2.0

150.53

168.70

3.03

262

1277

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

449

2313

1.31

6.88

1.7

2.3

100.16

97.75

0.76

411

2183

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

569

3027

1.27

6.83

3.6

4.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1448

8443

1.16

6.82

1.6

1.7

10438.70

13447.56

e6/l

2.35

999

6040

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

669

3631

1.25

6.78

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1386

8061

1.17

6.75

1.4

1.5

27.27

20.58

u/ml

0.55

157

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

633

3416

1.26

6.75

1.5

1.3

1.51

1.45

nmol/l

0.62

588

3078

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1640

9662

1.15

6.72

1.8

1.7

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

162

699

1.57

6.58

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1931

11525

1.14

6.55

2.7

2.8

3.59

g/l

0.00

1838

11071

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

335

1672

1.36

6.39

1.2

2.61

13.31

u/ml

2.64

191

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

104

403

1.75

6.38

1.0

0.24

0.30

u/ml

0.14

250

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

319

1583

1.36

6.32

1.1

14.28

9.24

u/ml

1.09

281

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

410

2113

1.31

6.31

1.1

1.11

u/l

0.06

156

874

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1675

9930

1.14

6.30

1.4

1.5

10.69

14.28

iu/ml

0.86

233

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

499

2643

1.28

6.25

1.4

11.20

12.51

umol/l

4.12

471

2498

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

346

1.80

6.25

1.0

1.1

0.18

1.04

u/ml

1.74

249

(3051651) Icteric interference index of Serum or Plasma

371

1890

1.33

6.20

3.2

3.9

0.82

0.88

index

0.51

364

1843

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

443

2315

1.30

6.17

1.5

27.92

23.95

u/ml

0.73

417

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

368

1.76

6.13

1.0

1.1

0.53

5.81

u/ml

0.58

182

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1015

5809

1.18

6.07

1.1

1.2

1.19

1.07

0.16

273

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

670

3686

1.23

6.06

1.2

64.20

64.76

u/l

0.06

583

3258

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

394

2032

1.31

6.05

1.3

425.77

530.24

titre

0.19

127

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

254

1227

1.40

5.95

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

384

1980

1.31

5.92

1.3

94.48

73.66

titre

0.19

145

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

164

730

1.52

5.86

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

164

731

1.52

5.82

1.1

—

(3036603) Volume of Urine

492

2629

1.27

5.78

1.5

1.7

2119.29

1986.86

1.89

487

2572

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1523

9030

1.14

5.76

1.4

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1020

5870

1.18

5.74

1.1

0.30

3.68

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

163

730

1.51

5.68

1.1

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

2.64

5.58

1.3

1.4

169.67

116.62

nmol/l

1.04

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

905

5170

1.19

5.57

1.1

1.48

1.50

g/l

1.12

836

4744

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

974

5600

1.18

5.56

1.4

1.5

14.20

13.81

u/ml

0.03

121

(3051387) C reactive protein [Mass/volume] in Capillary blood

888

7086

0.84

5.56

3.8

3.3

22.54

26.84

mg/l

3.54

569

4869

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

395

1.70

5.55

1.0

1.1

0.42

2.40

u/ml

1.89

304

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

270

1336

1.37

5.52

1.1

1.0

9.79

11.21

u/ml

0.53

176

865

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

671

3742

1.21

5.37

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

107

440

1.65

5.37

1.0

4.39

2.27

u/ml

0.20

209

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4634

33564

0.93

5.34

3.4

4.4

15.03

25.75

ug/l

1.88

3562

26997

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

397

2088

1.29

5.33

1.2

1.3

26.97

24.71

u/l

0.27

329

1777

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1130

6598

1.16

5.33

1.4

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

105

432

1.64

5.27

1.0

0.30

0.78

u/ml

0.66

208

(3044242) Glucose [Moles/volume] in Arterial blood

329

1696

1.31

5.15

2.1

2.0

8.23

8.09

mmol/l

0.23

329

1696

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

305

1556

1.33

5.14

1.1

95.27

97.75

0.78

244

1242

(3033923) Metanephrine [Moles/time] in 24 hour Urine

145

649

1.51

5.11

1.1

1.28

2.83

umol/24h

0.32

329

(3027974) Hepatitis B virus e Ag [Presence] in Serum

225

1.89

5.10

1.7

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3139

19517

1.09

5.08

9.0

10.4

16.25

16.10

2.15

3053

18825

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

295

1501

1.33

5.07

2.5

51.08

51.87

umol/l

0.15

256

1315

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

221

1.90

5.05

1.0

22.69

16.61

u/ml

0.36

175

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

184

867

1.44

5.03

1.6

0.40

ug/l

0.06

136

629

(3008116) Ketones [Moles/volume] in Urine by Test strip

166

767

1.46

5.02

1.8

1.4

0.24

0.33

mmol/l

0.54

130

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

403

2142

1.27

5.01

1.2

1.3

88.26

92.07

u/l

0.29

340

1851

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

111

470

1.60

5.00

1.0

—

(3051611) Lipemic interference index of Serum or Plasma

586

3250

1.22

4.99

3.2

3.5

14.83

14.31

index

0.31

364

1846

(3014148) Varicella zoster virus Ab [Titer] in Serum

970

5630

1.17

4.98

1.2

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

296

1.76

4.96

1.5

1.3

19.34

16.91

nmol/l

0.31

(3023383) Lactate [Moles/volume] in Pleural fluid

927

0.60

4.94

1.4

1.3

3.85

3.33

mmol/l

0.48

854

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1335

7941

1.14

4.89

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

104

436

1.61

4.88

1.0

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

172

2.01

4.87

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

268

1.79

4.86

1.0

1.1

0.04

0.51

u/ml

0.91

268

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

166

773

1.45

4.85

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

279

1.77

4.81

1.0

0.35

0.71

u/ml

0.43

159

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

232

1148

1.37

4.81

2.7

3.1

26.52

29.01

umol/l

2.73

167

885

(3035320) C reactive protein [Mass/volume] in Body fluid

497

2723

1.24

4.78

3.3

2.6

26.73

28.14

mg/l

0.33

350

1953

(3040151) Glucose [Moles/volume] in Capillary blood

684

3869

1.20

4.78

13.5

5.8

7.34

7.28

mmol/l

0.09

570

3193

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

180

854

1.43

4.77

1.2

1.3

104.41

107.25

0.58

171

815

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

292

1500

1.32

4.73

1.1

774.08

350.31

ng/l

0.36

409

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

263

1.77

4.60

1.0

3.10

0.69

u/ml

0.49

245

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

587

3289

1.21

4.56

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

568

3174

1.21

4.54

1.2

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

408

1.61

4.53

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

196

955

1.39

4.49

1.6

1.7

9.41

9.29

ug/l

0.13

196

955

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

221

1.84

4.48

1.2

1.3

7.09

4.05

u/ml

0.30

182

(3006270) Folate [Moles/volume] in Blood

451

2465

1.24

4.47

1.1

1.2

401.19

367.71

nmol/l

3.03

419

2066

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

561

3137

1.21

4.46

1.3

1.2

62.30

70.38

u/ml

0.24

116

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

146

676

1.46

4.43

1.3

1.2

97.61

58.94

mg/l

0.32

100

474

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

566

3171

1.21

4.42

1.2

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

132

602

1.48

4.33

1.1

3.68

37.65

iu/ml

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

291

1515

1.30

4.32

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

573

3224

1.20

4.29

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

658

3752

1.19

4.26

1.2

51.14

45.09

u/ml

0.21

193

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

548

3074

1.21

4.24

1.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

405

1.59

4.23

1.0

2.83

0.51

u/ml

0.44

198

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

2.30

4.19

1.0

0.32

0.77

u/ml

0.70

(3012516) Albumin [Mass/volume] in Urine

16236

106662

1.04

4.15

3.4

3.6

44.51

49.81

mg/l

1.73

10250

68068

(3013945) Hepatitis B virus e Ab [Presence] in Serum

217

1.81

4.15

1.7

1.4

—

(3016031) Almond IgE Ab [Units/volume] in Serum

308

1.67

4.13

1.0

1.1

0.34

0.75

u/ml

1.61

180

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1825

11176

1.11

4.13

3.8

3.9

1.38

1.49

mg/l

7.78

1684

10308

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.25

4.12

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

381

2066

1.25

4.10

1.9

2.0

105.79

100.31

ng/l

0.32

381

2060

(3007542) Rye IgE Ab [Units/volume] in Serum

218

1.80

4.09

1.0

0.45

9.45

u/ml

0.50

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

227

1151

1.33

4.09

1.2

1.1

8.50

5.04

u/ml

0.50

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

253

1.74

4.09

1.0

2.33

2.02

u/ml

0.06

202

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

119

2.10

4.05

1.0

1.1

0.04

0.11

u/ml

0.44

119

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

268

1394

1.30

4.04

2.7

130.99

153.27

au/ml

0.37

204

(3025296) Carrot IgE Ab [Units/volume] in Serum

2.44

3.98

1.0

1.95

0.72

u/ml

0.31

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

166

805

1.40

3.97

1.2

96.83

86.73

1.06

232

(3007700) Barley IgE Ab [Units/volume] in Serum

191

1.84

3.96

1.0

0.49

7.89

u/ml

0.49

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

230

1177

1.32

3.91

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

484

2707

1.21

3.90

1.2

44.63

52.30

u/ml

0.22

180

(3001893) Eosinophils/Leukocytes in Pleural fluid

873

0.64

3.90

1.4

3.61

2.82

0.33

735

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

710

4115

1.17

3.83

1.2

1.1

0.75

2.05

iu/ml

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

532

3009

1.20

3.82

1.2

98.75

211.83

titre

—

104

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

533

3017

1.20

3.80

1.2

207.86

203.22

titre

0.04

466

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3226

20343

1.08

3.78

6.6

7.0

24.50

24.52

mmol/l

0.12

3125

19453

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

653

3765

1.17

3.76

2.9

3.5

3.70

8.92

nmol/l

1.79

633

3639

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

541

3071

1.19

3.74

1.2

—

(3018133) Calcium [Moles/volume] in Urine

155

755

1.39

3.65

2.1

2.0

2.53

2.76

mmol/l

0.77

141

697

(3013247) Albumin in CSF/Albumin in Serum or Plasma

171

847

1.37

3.64

1.1

6.74

7.13

mg/g

0.24

166

808

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

164

807

1.37

3.63

1.2

79.88

76.03

0.24

222

(3036071) Salmonella sp Ab [Titer] in Serum

226

1168

1.31

3.62

1.1

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

331

1.59

3.60

1.7

1.6

—

(3018333) Ribosomal P Ab [Presence] in Serum

526

2992

1.19

3.58

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1092

6557

1.13

3.57

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

299

1605

1.26

3.57

1.1

0.11

0.48

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

294

1579

1.26

3.50

3.7

3.5

8.50

8.68

mg/l

0.17

233

1282

(3000060) B lymphocytes [#/volume] in Blood

227

1180

1.30

3.50

2.5

2.2

0.18

0.58

e9/l

1.04

116

556

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

350

2900

0.81

3.48

1.3

467.95

507.16

u/l

0.18

332

2747

(3012494) Peanut IgE Ab [Units/volume] in Serum

212

1095

1.31

3.43

1.1

47.42

9.34

u/ml

0.43

128

646

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

140

678

1.40

3.43

1.4

1.3

1.18

mmol/l

0.08

140

678

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

838

4962

1.14

3.42

1.3

1.4

6.97

7.06

mmol/l

0.43

765

4381

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

278

1.63

3.40

1.1

86.45

95.31

titre

0.49

278

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2606

16380

1.08

3.36

3.9

4.1

51.17

47.77

9.72

2571

16163

(3003843) Paprika IgE Ab [Units/volume] in Serum

2.13

3.34

1.0

1.1

0.05

0.08

u/ml

0.43

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

125

1.95

3.29

2.1

2.0

259.93

241.91

ug/l

0.20

125

(3003129) Base excess in Capillary blood by calculation

669

3912

1.16

3.28

2.1

2.2

0.64

0.49

mmol/l

0.50

638

3738

(4035726) Immunohistochemistry procedure

4141

29589

0.94

3.26

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

449

1.48

3.25

1.9

1.7

—

(3016750) Collection duration of Urine

212

1841

0.78

3.23

2.0

2.3

507.36

499.80

min

0.47

148

1405

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

407

1.50

3.19

1.8

1.70

1.76

mg/l

0.16

344

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

174

885

1.33

3.17

1.1

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

284

1.60

3.16

1.4

7.43

14.50

pmol/l

2.04

239

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

105

491

1.45

3.15

1.8

1.5

217862.70

209120.66

nmol/l

0.02

406

(3035947) Staphylolysin Ab [Units/volume] in Serum

308

1686

1.24

3.15

1.2

1.1

3.72

3.62

iu/ml

0.07

128

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

246

1314

1.27

3.12

2.2

2.1

71.52

60.52

ug/l

1.01

239

1290

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

204

1064

1.30

3.12

4.5

2.9

4.84

4.93

kpa

0.68

204

1064

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

204

1064

1.30

3.12

4.5

2.9

10.65

10.43

kpa

0.43

204

1064

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

228

1.66

3.09

1.1

8.96

8.74

u/l

0.04

228

(3026051) Granulocytes/Leukocytes in Pleural fluid

689

0.65

3.09

1.4

20.56

23.46

0.38

572

(3000330) Specific gravity of Urine by Test strip

2306

16768

0.93

3.07

3.0

3.3

1.02

ratio

4.21

2016

15023

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

244

0.42

3.04

1.1

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

985

5945

1.12

3.03

1.2

1.1

241.68

2578.29

iu/ml

0.70

219

1240

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

442

0.57

3.02

1.4

11.92

13.32

0.12

225

(3032057) Clostridioides difficile [Presence] in Stool

124

603

1.39

3.02

1.7

1.8

—

(3003434) Protein [Mass/volume] in Pleural fluid

532

4186

0.86

3.01

1.5

1.4

33.29

40.47

g/l

0.49

488

3808

(3010375) cycloSPORINE [Mass/volume] in Blood

189

1648

0.77

3.01

26.5

30.2

109.65

118.34

ug/l

1.06

155

1353

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

249

0.43

2.92

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

201

1.68

2.91

1.2

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

978

7371

0.90

2.87

2.2

2.4

117.67

108.29

ug/min

0.21

573

4442

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

114

554

1.39

2.82

1.0

0.26

0.27

u/ml

0.01

344

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

172

893

1.30

2.77

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

7927

55501

0.96

2.76

3.1

3.0

0.66

0.76

ug/l

9.12

4664

33987

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

348

1959

1.20

2.76

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

233

0.44

2.74

3.1

5.9

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

110

1018

0.73

2.71

1.4

57.08

62.91

1.05

832

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

115

564

1.38

2.71

1.8

2.0

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

115

564

1.38

2.71

1.8

1.9

39.17

56.42

pmol/l

0.62

483

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.22

2.70

1.3

2.9

2.27

3.06

mu/l

0.24

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

101

485

1.41

2.69

2.0

2.5

1.12

1.31

mmol/l

0.40

330

(3020682) Albumin/Creatinine [Ratio] in Urine

16414

108557

1.03

2.67

4.0

4.3

7.70

8.82

mg/mmol

2.30

10119

67929

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

708

4225

1.13

2.67

2.1

2.2

32.57

32.42

0.40

702

4198

(3042733) HLA Ab [Presence] in Serum

157

1374

0.77

2.62

5.5

5.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1051

6425

1.11

2.62

1.2

1.3

127.50

132.99

titre

—

134

(40768806) Pleura Pathology biopsy report

393

3125

0.85

2.60

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

173

908

1.29

2.59

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

629

0.67

2.59

1.1

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

168

879

1.29

2.58

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

113

559

1.37

2.55

1.4

75.27

244.34

ng/l

0.59

362

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

834

0.71

2.54

1.3

75.67

278.58

ug/l

2.26

445

(40761539) Cells [Type] in Urine sediment by Light microscopy

149

769

1.31

2.54

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1902

13817

0.93

2.54

4.8

5.2

0.88

0.12

1805

13071

(21491868) Cryoglobulin [Mass/volume] in Serum

235

1285

1.24

2.52

1.2

0.12

0.53

g/l

—

(3035880) pH of Pleural fluid

188

1598

0.79

2.49

1.2

1.3

7.41

0.00

118

1132

(40757373) Influenza virus identified in Isolate

615

0.67

2.49

1.5

1.6

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

118

591

1.35

2.47

2.6

2.5

1.20

1.19

mmol/l

0.54

111

564

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

227

1.58

2.47

1.6

1.4

40.30

36.99

0.25

151

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

292

1.51

2.46

1.0

1.1

13.83

7.09

u/ml

0.84

174

(3024471) HLA-A [Type]

143

1253

0.77

2.44

1.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

507

3933

0.87

2.44

1.9

2.0

26.32

25.40

ug/l

0.07

498

3852

(3020491) Glucose [Moles/volume] in Blood

435

2527

1.17

2.44

1.5

1.7

6.68

6.67

mmol/l

0.02

354

1853

(3021661) Pineapple IgE Ab [Units/volume] in Serum

2.25

2.42

1.0

0.04

0.20

u/ml

—

(3024932) HLA-DR beta [Type]

140

1228

0.77

2.42

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

367

2105

1.18

2.41

1.8

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

256

1.53

2.39

1.1

1.0

—

(3035060) Mercury [Moles/volume] in Blood

2.35

2.36

2.5

1.5

11.44

10.11

nmol/l

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

928

5674

1.11

2.35

1.2

1.3

27.49

33.11

u/l

0.57

804

4959

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

331

1889

1.19

2.32

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

432

2520

1.16

2.32

2.2

2.6

551.00

529.61

e6/l

0.26

334

2023

(3013466) aPTT in Blood by Coagulation assay

215

1.57

2.31

1.3

1.1

35.57

36.98

0.99

185

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

369

1.43

2.31

1.1

—

(3033099) Centromere Ab [Titer] in Serum

167

889

1.27

2.29

1.1

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

3.38

2.29

1.0

1.1

17.67

18.44

umol/l

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

204

1112

1.24

2.29

1.7

149.93

124.26

au/ml

0.26

163

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

333

1908

1.18

2.24

1.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

480

1.37

2.23

1.7

1.6

110.87

111.33

ug/l

0.01

393

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

266

1.50

2.23

1.1

16.45

23.28

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

266

1.50

2.23

1.1

27.82

29.66

u/ml

0.04

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

356

2053

1.17

2.22

1.6

6.00

7.04

u/l

0.79

275

1639

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

103

515

1.35

2.22

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

114

579

1.33

2.22

1.9

2.6

1.19

1.18

mmol/l

0.43

108

550

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

266

1496

1.20

2.21

2.0

2.2

8.90

9.17

mg/l

0.32

216

1238

(40765096) Chromosome analysis panel by Banding

112

998

0.76

2.21

1.1

1.2

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

327

2598

0.85

2.20

1.5

1.7

—

(3000034) Microalbumin [Mass/volume] in Urine

465

2739

1.15

2.20

3.1

3.0

49.68

54.80

mg/l

0.19

334

1954

(3007919) Fasciola sp Ab [Titer] in Serum

2.05

2.17

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

174

0.43

2.17

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.88

2.15

1.1

1.2

27.79

45.97

umol/24h

0.58

(3026250) Tacrolimus [Mass/volume] in Blood

224

1835

0.82

2.15

43.8

43.0

7.32

7.30

ug/l

0.07

207

1670

(3041672) Baker's yeast Ab [Presence] in Serum

214

1.55

2.15

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

174

1462

0.80

2.14

3.2

3.3

1.51

1.31

0.75

174

1462

(3013637) Mi-2 Ab [Presence] in Serum

172

928

1.25

2.14

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

172

928

1.25

2.14

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

172

928

1.25

2.14

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

172

928

1.25

2.14

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

617

3712

1.13

2.13

1.4

8.74

8.23

mmol/l

1.97

596

3549

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1806

13046

0.93

2.12

2.0

1.62

2.38

ug/l

2.83

1586

11603

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

141

1.68

2.11

1.1

346.45

471.13

u/l

0.42

116

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1031

6379

1.09

2.09

1.2

1.3

284.50

303.94

titre

0.11

476

(3006245) CD3-CD19+ cells/cells in Blood

273

1549

1.19

2.09

2.6

2.3

9.72

10.14

0.26

262

1448

(40765089) Chromosome analysis panel - Blood by G-banded

260

1469

1.20

2.08

1.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

6039

39435

1.04

2.08

4.9

4.7

31.92

32.25

1.46

4249

27233

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

286

2279

0.85

2.03

1.3

13.32

14.65

u/l

0.50

265

2095

(3001218) Citrate [Mass/time] in 24 hour Urine

1.99

2.03

1.5

413.65

400.54

mg/24h

0.07

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

169

1.60

2.03

1.6

1.3

1.91

1.65

0.10

110

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1357

8511

1.08

2.01

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

426

1.37

2.00

2.3

2.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

329

1.42

2.00

1.0

0.04

0.05

u/ml

0.62

329

(3033942) Copper [Moles/time] in 24 hour Urine

165

1.60

1.97

1.3

1.05

0.77

umol/24h

0.19

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

208

1.53

1.97

1.0

1.1

56.42

54.77

u/l

0.06

173

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

440

0.66

1.96

1.4

1.2

28.52

222.15

u/l

1.16

316

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1661

11994

0.93

1.96

3.2

3.6

279.84

1889.61

u/ml

2.29

1408

10368

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

279

0.58

1.90

3.1

2.2

75.20

58.70

—

174

(44806071) Cardiolipin IgM antibody measurement

100

512

1.32

1.90

1.1

—

(3024263) Appearance of Synovial fluid

278

1597

1.18

1.88

1.7

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

259

1479

1.18

1.88

2.3

2.2

27.15

29.67

2.67

250

1412

(1617658) Protocol used for examination of sentinel lymph nodes

410

2427

1.14

1.87

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

217

0.53

1.87

1.1

1.3

—

(3022229) Phosphate [Moles/volume] in Urine

255

1.46

1.87

2.8

1.9

18.78

19.75

mmol/l

0.14

215

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1443

9101

1.07

1.86

1.5

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1131

7069

1.08

1.85

2.5

2.2

0.89

0.86

nmol/l

0.54

963

6017

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

261

1.45

1.85

1.2

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

250

1.46

1.85

1.1

4.37

1.19

u/ml

0.78

171

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

250

1.46

1.85

3.1

3.0

11.51

384.22

pmol/l

0.68

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1400

8824

1.07

1.85

1.5

1.6

—

(37208534) Antinuclear antibody arbitrary concentration in serum

227

1284

1.20

1.84

1.1

—

(3028433) Virus identified in Specimen by Culture

189

1052

1.22

1.82

1.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

101

1.74

1.81

2.9

2.8

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

175

1.55

1.79

1.2

1.1

1.07

1.21

u/field

0.87

117

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.11

1.79

1.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

101

882

0.77

1.78

1.2

1.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

512

1.31

1.77

1.1

—

(3003577) Lead [Moles/volume] in Blood

309

1.40

1.77

1.6

1.5

0.22

0.37

umol/l

0.87

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

154

842

1.24

1.76

1.2

64.56

68.38

ug/l

0.44

154

842

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

226

1284

1.19

1.76

1.1

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

242

1.45

1.75

1.3

1.4

16.37

15.50

pmol/l

0.08

209

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

437

2612

1.13

1.75

2.3

2.7

223.83

228.45

e6/l

0.19

356

2207

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

539

0.71

1.74

1.6

2.0

—

(40758292) HTLV I+II Ab panel - Serum

755

0.76

1.72

1.2

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

253

1457

1.17

1.70

3.9

4.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

422

1.33

1.69

1.1

—

(3022475) Manganese [Moles/volume] in Blood

200

1.49

1.67

1.3

0.15

0.16

umol/l

0.08

200

(3047189) Immunofixation for 24 hour Urine

177

1440

0.83

1.66

1.8

1.9

—

(3012441) Differential panel - Pleural fluid

416

3170

0.89

1.65

1.5

—

1.00

—

(44790048) Parainfluenza type 2 nucleic acid detection

744

4601

1.09

1.61

1.4

1.6

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

153

1.55

1.60

1.5

0.29

0.16

u/l

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

448

2700

1.12

1.59

1.1

1.2

—

(44790049) Parainfluenza type 3 nucleic acid detection

743

4598

1.09

1.59

1.4

1.6

—

(44806118) Parainfluenza type 4 nucleic acid detection

743

4599

1.09

1.58

1.4

1.6

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

151

1240

0.82

1.58

2.0

659.19

2544.22

e6/l

1.46

820

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

203

1.47

1.58

1.8

1.4

13.16

12.68

0.06

145

(44790047) Parainfluenza type 1 nucleic acid detection

743

4602

1.09

1.57

1.4

1.6

—

(3011412) CD3 cells [#/volume] in Blood

574

3512

1.11

1.56

2.2

2.5

1324.61

1208.64

e6/l

1.70

487

3076

(21494815) CD4 cells/Lymphocytes in Specimen

529

3223

1.11

1.56

2.3

42.45

38.61

7.60

521

3170

(3007147) Virus identified in Stool by Electron microscopy

3.12

1.55

1.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

271

1584

1.16

1.54

3.1

5.0

3152.14

2128.51

mg/l

0.28

190

1147

(3018851) Theophylline [Moles/volume] in Serum or Plasma

244

1.41

1.52

1.6

1.8

50.57

46.99

umol/l

0.25

244

(3037121) Protein [Mass/volume] in Urine

1817

11636

1.06

1.52

3.1

3.5

758.55

500.79

mg/l

0.58

791

5512

(3011325) HIV 1+2 Ab [Presence] in Serum

166

1.51

1.52

1.1

1.0

0.09

0.08

0.37

118

(3017704) Immunofixation for Urine

217

1718

0.85

1.52

1.5

1.7

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

118

640

1.25

1.50

2.3

2.8

31.82

44.76

mg/l

0.54

159

(3012403) Metanephrines [Moles/time] in 24 hour Urine

1.90

1.48

1.1

33.50

26.98

umol/24h

—

(3047181) Lactate [Moles/volume] in Blood

1590

10155

1.06

1.47

4.9

5.7

1.32

1.30

mmol/l

0.30

1423

8988

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

124

1.58

1.47

1.1

—

(3028468) Fragments [Presence] in Blood by Light microscopy

2.63

1.46

3.1

1.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

977

6141

1.08

1.46

2.5

3.1

2767.12

6007.19

u/ml

0.61

351

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3786

24695

1.04

1.46

2.7

3.0

160.05

189.65

ng/l

4.34

3437

22530

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

135

1.55

1.46

1.1

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

513

0.74

1.45

1.2

1.50

1.30

mmol/l

0.09

338

(3004541) Aldosterone [Moles/volume] in Urine

2.90

1.45

1.3

1.1

41.67

37.21

nmol/l

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

517

1.27

1.44

1.9

2.1

—

(3034614) HLA Ag [Interpretation]

1.71

1.42

1.0

1.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

118

646

1.24

1.40

1.1

1.2

—

(40759632) Porphyrins [Mass/mass] in Stool

2.25

1.40

1.3

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

563

0.76

1.39

5.5

6.8

10.95

10.63

0.45

563

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

330

1.33

1.39

1.0

1.1

1.72

2.83

umol/24h

0.49

330

(3012565) Volume of 24 hour Urine

282

1669

1.14

1.38

2.1

2.2

2008.67

1988.05

0.10

254

1511

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

328

1962

1.13

1.37

1.1

80.58

82.86

u/l

0.19

293

1755

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

478

2922

1.11

1.37

1.3

80.90

79.75

0.11

212

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1032

6521

1.07

1.36

1.3

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

100

1.62

1.36

1.2

33.78

32.85

mg/24h

0.08

100

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

342

0.69

1.35

1.1

1.2

0.11

0.34

u/ml

1.16

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

243

1426

1.15

1.35

2.4

2.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

659

0.78

1.35

1.1

1.4

250.00

142952.03

u/ml

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

107

583

1.24

1.34

1.3

987.11

229.02

titre

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

236

0.63

1.34

2.2

2.6

—

(42870560) Thyrotropin [Units/volume] in Cord blood

177

0.57

1.33

1.0

11.75

8.44

mu/l

1.05

146

(3017569) Oxygen content in Arterial blood

292

1738

1.14

1.33

2.4

2.2

16.28

15.93

0.98

292

1738

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.69

1.32

1.5

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

2.18

1.31

1.1

1.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

325

1951

1.13

1.30

1.2

1.1

22.51

23.29

u/l

0.09

293

1743

(3044007) Cell count panel - Peritoneal fluid

129

1049

0.83

1.28

2.0

1.9

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

400

1.28

2.3

3.4

41.33

41.74

umol/l

0.06

345

(4281824) Cell count and differential, peritoneal fluid

512

3794

0.91

1.28

1.1

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

131

1062

0.83

1.26

1.9

13017.39

11253.87

e6/l

0.09

535

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

318

1.32

1.26

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.98

1.26

1.1

4042.17

3520.83

titre

0.26

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

105

869

0.82

1.26

8.6

8.1

5.92

5.97

kpa

0.29

774

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

260

1.35

1.25

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

409

2496

1.11

1.24

2.1

2.6

0.79

0.68

e9/l

2.85

391

2401

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

180

1041

1.17

1.24

1.8

1.7

146.20

202.73

iu/ml

—

(3049233) Organic acids panel - Urine

1.81

1.24

1.2

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

249

1.36

1.24

1.9

3.4

14.20

10.59

0.35

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

155

0.57

1.22

1.2

1.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1241

7930

1.06

1.19

4.2

6.2

5339.76

1057.95

iu/ml

0.45

137

1176

(3002619) Bacteria identified in Specimen by Culture

160

920

1.18

1.19

1.3

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.72

1.19

1.1

2.94

2.66

0.18

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.93

1.19

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.93

1.19

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.93

1.19

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.93

1.19

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.93

1.19

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.93

1.19

2.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2145

15123

0.96

1.18

4.5

5.0

1.75

1.64

3.36

2044

14341

(3013862) HLA-DP [Type]

153

0.57

1.17

1.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1867

12066

1.05

1.17

1.9

1.8

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

106

0.51

1.17

1.0

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2035

13179

1.05

1.17

2.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

286

1719

1.13

1.16

1.5

1.8

2.35

2.52

u/field

0.15

212

1231

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

102

565

1.22

1.14

1.1

—

(1175426) CD3 cells/Lymphocytes in Blood

462

2854

1.10

1.12

2.2

2.1

74.72

72.77

2.52

445

2752

(40760410) HLA-B [Type] by High resolution

151

0.58

1.12

1.0

—

(40760409) HLA-A [Type] by High resolution

151

0.58

1.12

1.1

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

217

0.65

1.12

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

139

1.46

1.12

1.0

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

504

3127

1.09

1.12

1.4

136459.27

111266.27

e6/l

0.32

330

2059

(3023199) Leukocytes [#/volume] in Pleural fluid

507

3730

0.92

1.12

1.5

1.4

4375.62

3341.31

e6/l

0.43

339

2613

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

169

1324

0.86

1.12

1.5

1.8

12710.29

24143.84

u/ml

0.43

182

(3001729) Color of Synovial fluid

241

0.67

1.11

2.3

1.6

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

266

1.32

1.11

1.3

1.2

99.24

101.79

ug/l

0.04

162

(3008536) Aspergillus sp Ab [Presence] in Serum

737

0.82

1.11

1.6

2.2

—

(3044927) Protein electrophoresis panel - Urine

402

2985

0.91

1.09

1.2

—

(3008896) Cortisol [Moles/volume] in Urine

2.25

1.09

1.1

1.2

251.14

79.33

nmol/l

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

291

1.30

1.08

1.1

1.0

6.60

4.20

u/ml

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

109

881

0.84

1.06

1.6

1.9

30.01

39.40

u/l

0.28

804

(3006840) Garlic IgE Ab [Units/volume] in Serum

1.84

1.06

1.0

0.06

0.72

u/ml

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

388

1.25

1.05

1.1

1.3

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

1.64

1.04

1.0

0.02

0.10

u/ml

0.68

(3022670) pH of Venous cord blood

1.64

1.04

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

155

902

1.16

1.03

1.6

1.8

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

204

0.66

1.02

2.6

1.7

0.47

0.65

0.35

155

(3026692) Albumin [Mass/volume] in Peritoneal fluid

110

884

0.84

1.02

1.5

1.4

12.84

13.66

g/l

0.41

669

(3027923) C peptide [Moles/volume] in Serum or Plasma

328

2005

1.11

1.02

1.6

1.17

1.30

nmol/l

1.53

246

1533

(3018572) Chloride [Moles/volume] in Blood

968

6927

0.94

1.01

6.2

6.8

104.73

105.11

mmol/l

1.61

892

6242

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

2.06

1.01

1.1

1.0

0.86

0.93

u/ml

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

1.00

0.0

1.2

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

1.00

0.0

1.2

—

(3039000) Anion gap in Blood by calculation

968

6926

0.94

1.00

6.2

6.8

11.53

11.25

mmol/l

1.79

892

6239

(3037692) Legionella sp identified in Specimen by Organism specific culture

148

1159

0.86

1.00

1.3

1.5

—

(3019174) dRVVT (LA screen)

313

1.27

0.99

1.2

—

(3024316) Viscosity of Plasma

166

1.38

0.99

1.8

1.7

1.79

1.54

mpas

0.63

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

309

1887

1.11

0.99

1.3

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

442

2746

1.09

0.99

2.2

2.1

13.31

14.88

3.32

432

2677

(40768795) Lymph node Pathology biopsy report

476

3487

0.92

0.98

1.2

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

2.39

0.97

1.0

1.1

24.17

32.53

umol/l

—

(46236302) HLA-C [Type] by High resolution typing

152

0.62

0.96

1.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

148

866

1.16

0.94

2.5

2.8

114.32

104.51

ng/l

0.36

478

(3038071) Oxygen [Partial pressure] in Mixed venous blood

773

0.84

0.93

8.7

8.0

5.83

5.67

kpa

0.20

773

(40763590) HLA-DQ beta [Type]

150

0.63

0.91

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

515

3233

1.08

0.91

1.1

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

464

1.21

0.90

1.2

1.1

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

2.03

0.87

1.7

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

332

1.24

0.86

1.2

1.3

5.02

6.55

mmol/l

1.18

159

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

218

1.30

0.86

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

179

0.68

0.84

1.1

1.0

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

237

1.28

0.83

1.8

1.9

203.34

178.87

ug/g

0.42

202

(3028308) Erythrocytes [#/volume] in Pleural fluid

454

3303

0.93

0.83

1.5

1.4

72078.35

50552.50

e6/l

0.40

240

1858

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

317

1962

1.09

0.82

1.3

1.4

5.55

5.58

mmol/l

0.21

298

1857

(4212803) Bone marrow aspirate examination

250

1.27

0.81

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

421

1.20

0.81

2.7

3.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

143

847

1.14

0.81

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

173

1.33

0.81

1.0

1.1

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

492

3103

1.07

0.80

1.5

1.6

33.03

31.97

0.24

290

1929

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

196

1479

0.90

0.80

2.1

38.88

109.49

ug/min

2.88

335

(3032868) Hemoglobin electrophoresis panel in Blood

360

1.22

0.80

1.4

1.5

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

209

1.29

0.79

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.58

0.77

1.0

1.1

0.04

0.61

u/ml

1.33

(3029612) Listeria sp Ab [Titer] in Serum

1.52

0.77

1.4

1.3

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

2.11

0.75

1.0

1.2

19.10

35.09

ug/l

—

(3045788) Cell count panel - Pleural fluid

416

3020

0.93

0.74

1.5

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

807

5739

0.95

0.74

3.8

3.3

0.80

nmol/l

0.06

669

4592

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.64

0.74

1.0

0.07

0.13

u/ml

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

196

0.72

6.0

5.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

167

1261

0.90

0.72

1.6

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

167

1260

0.90

0.71

1.6

2.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

102

597

1.16

0.71

2.1

2.4

6.79

7.53

mmol/l

1.33

366

(3004809) Band form neutrophils/Leukocytes in Blood

793

5627

0.95

0.69

2.8

3.4

1.55

1.52

0.07

703

5054

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.41

0.68

1.1

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.53

0.68

2.2

1.3

0.45

2.76

mmol/l

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.45

0.68

1.7

1.4

1.43

2.08

mmol/24h

1.84

(3000012) Reticulocyte production index

699

4490

1.05

0.67

2.2

0.94

0.91

0.46

448

3056

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

108

1.38

0.67

1.0

7381.30

9562.62

ng/l

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

437

1.18

0.67

1.5

1.3

48.48

52.30

0.30

208

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

114

1.36

0.66

1.0

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

359

0.81

0.66

2.3

3.0

2.17

1.20

mg/l

0.84

241

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

329

0.80

0.66

1.0

1.1

25.02

21.13

u/l

0.69

215

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

388

0.82

0.66

2.0

2.4

0.70

0.64

u/field

0.13

388

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.39

0.65

1.0

0.92

4.12

u/ml

1.59

(3035153) Lemon IgE Ab [Units/volume] in Serum

1.78

0.65

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

332

2088

1.08

0.64

7.0

7.3

18.88

69.95

ug/l

2.01

209

1382

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1519

10609

0.97

0.63

3.4

0.36

0.35

iu/ml

0.29

791

5819

(4015189) Microbial culture of sputum

125

750

1.13

0.63

2.1

2.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

169

1032

1.11

0.63

2.1

3.3

1.99

1.83

ratio

0.58

153

952

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

171

1277

0.91

0.63

1.6

2.1

—

(3005570) Glucose [Moles/volume] in Urine

515

3289

1.06

0.63

2.1

1.9

14.66

17.68

mmol/l

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

446

2838

1.06

0.61

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

446

2838

1.06

0.61

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

446

2838

1.06

0.61

1.5

1.7

—

(40758358) Immune stain study

143

0.71

0.60

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

398

1.17

0.60

1.1

—

(3011829) Common Millet IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.10

—

(3042301) Urate [Moles/volume] in Synovial fluid

1.49

0.59

1.0

401.33

367.63

umol/l

—

(3020876) Protein [Mass/time] in 24 hour Urine

581

4132

0.95

0.59

2.3

2.5

1.17

1.31

g/24h

0.65

319

2508

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.55

0.58

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.55

0.58

1.0

1.1

—

(40768441) Liver Pathology biopsy report

374

2692

0.94

0.58

1.3

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

691

4463

1.05

0.57

1.5

1.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1658

10889

1.03

0.57

2.9

3.5

34.38

42.25

mg/l

2.21

1406

9247

(40762365) Oxygen content in Arterial blood by calculation

489

1.15

0.57

2.6

3.0

15.19

14.84

ml/dl

0.48

459

(3036048) Francisella tularensis Ab [Titer] in Serum

140

853

1.11

0.56

1.2

280.00

556.00

titre

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

234

1462

1.08

0.56

1.1

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

321

0.82

0.56

1.1

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

203

1.23

0.55

1.0

1.1

3.53

2.78

u/l

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

260

1633

1.08

0.55

1.3

1055.56

1049.72

titre

0.02

358

(3027570) Oxalate [Moles/time] in 24 hour Urine

234

1.21

0.54

1.7

1.5

307.19

313.93

umol/24h

0.08

234

(3007456) Orange IgE Ab [Units/volume] in Serum

1.35

0.54

1.0

0.01

0.18

u/ml

0.90

(4146454) Self-monitoring of blood glucose

483

3441

0.95

0.54

2.6

2.8

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

113

1.32

0.54

1.1

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

1.56

0.53

1.0

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

289

0.82

0.52

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

223

1.21

0.52

1.0

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

115

865

0.90

0.52

1.2

14.12

10.78

pmol/l

0.31

318

(3034860) Kappa light chains.free [Mass/volume] in Serum

1657

10906

1.03

0.51

2.9

3.5

47.86

66.86

mg/l

1.30

1403

9261

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

206

1287

1.08

0.51

2.6

2.9

0.62

0.61

mmol/l

0.58

206

1287

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

153

0.75

0.50

3.0

3.3

—

(4038314) Semen analysis, post vasectomy

343

1.16

0.50

1.3

1.2

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

163

1.24

0.50

1.0

1.1

21.61

21.25

0.17

151

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

1.45

0.49

1.0

0.35

2.70

u/ml

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

451

1.14

0.49

2.8

2.9

54.83

75.01

pmol/l

1.09

391

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

145

1.26

0.49

7.9

9.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

561

3625

1.05

0.48

1.5

1.7

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

1.53

0.48

1.1

1.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

239

1506

1.07

0.48

1.2

1.4

—

(4211845) Urine protein measurement

268

1696

1.07

0.48

2.6

3.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

239

1507

1.07

0.48

1.2

1.4

—

(3044009) aPTT.lupus sensitive (LA screen)

332

1.16

0.48

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

398

2553

1.05

0.47

1.5

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.34

0.47

1.1

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

362

2580

0.95

0.44

1.7

2.0

2.02

2.90

u/field

0.46

210

1450

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

157

0.78

0.44

3.1

3.8

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

1.69

0.44

1.0

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

282

0.84

0.43

1.4

1.3

1.40

1.49

ml/s/173m2

0.11

182

(3045177) Copper [Moles/volume] in Urine

1.40

0.42

1.1

0.38

0.37

umol/l

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.71

0.42

2.7

5.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1468

9682

1.03

0.42

2.8

3.4

3.29

5.55

ratio

0.83

797

5548

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

218

1574

0.94

0.42

1.1

—

(3027874) Urate [Moles/volume] in Urine

124

1.25

0.42

1.0

1.1

1.77

6.18

mmol/l

0.50

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

324

0.86

0.41

1.8

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

359

2551

0.95

0.41

1.2

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

180

1.20

0.41

1.6

1.9

178.23

204.12

ng/l

1.42

160

(3009677) Dengue virus Ab [Presence] in Serum

168

1.21

0.40

1.1

—

(3034426) Prothrombin time (PT)

191

1206

1.07

0.40

1.2

28.50

28.08

0.49

191

1206

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

109

0.74

0.40

1.1

1.0

—

(3023419) Bacteria identified in Sputum by Culture

648

4226

1.04

0.40

2.4

2.7

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

459

0.88

0.39

8.8

9.3

0.36

0.41

umol/l

0.34

407

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

139

0.78

0.39

1.1

—

(40760512) CD34 cells/cells in Bone marrow

1.41

0.38

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

416

1.12

0.38

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

720

0.91

0.38

1.2

—

(3037756) Immunofixation for Serum or Plasma

952

6621

0.97

0.38

1.5

1.7

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

514

3612

0.96

0.37

1.2

1.3

37.40

56.48

u/ml

—

(3006576) Bicarbonate [Moles/volume] in Blood

163

1027

1.07

0.37

5.2

6.4

24.67

25.15

mmol/l

0.81

155

927

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

300

1928

1.05

0.37

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

790

5182

1.03

0.36

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

443

3119

0.96

0.36

1.4

—

(3040794) Aluminum [Moles/volume] in Urine

0.61

0.36

1.0

1.3

0.25

0.38

umol/l

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

287

1845

1.05

0.35

1.5

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

457

2972

1.04

0.34

2.4

2.6

982.63

1120.42

0.90

451

2942

(3027035) Albumin [Mass/time] in 24 hour Urine

318

0.87

0.34

1.5

1.3

95.00

337.62

mg/24h

—

(46235168) Fasting glucose [Moles/volume] in Blood

475

0.90

0.34

1.1

1.8

6.02

7.45

mmol/l

2.24

138

(3045142) Bone marrow Pathology biopsy report

525

3679

0.96

0.34

1.2

1.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

228

1.16

0.34

1.0

1.2

—

(21494434) Karyotype in Bone marrow

401

2825

0.96

0.34

1.1

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

224

0.85

0.34

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

260

1.14

0.34

1.2

1.1

—

0.30

—

(3010503) CD19 cells [#/volume] in Blood

327

2112

1.05

0.34

2.2

2.7

146.58

302.33

e6/l

2.13

315

2060

(3032641) Amino acids panel - Urine

1.38

0.34

1.5

1.3

—

(3034891) Synovial lining cells/cells in Synovial fluid

259

1664

1.05

0.33

1.4

1.5

4.02

3.84

0.06

360

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

513

3347

1.04

0.33

1.5

1.6

7.65

7.66

mmol/l

0.03

499

3209

(3033086) Enterovirus Ab [Titer] in Serum

116

1.22

0.33

1.1

1.0

—

(3014891) Appearance of Pleural fluid

366

0.89

0.32

1.8

1.5

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

633

4149

1.03

0.32

1.5

1.6

51.92

56.70

2.07

390

2637

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

483

3151

1.04

0.32

1.6

1.9

—

(3041184) Isoniazid [Presence] in Urine

1.39

0.32

1.6

2.7

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

1.39

0.32

1.0

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

466

3266

0.96

0.32

1.9

2.1

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

123

1.21

0.31

1.0

0.10

0.13

u/ml

—

(3045462) Protein/Creatinine [Ratio] in Urine

513

1.09

0.31

5.4

4.4

45.46

50.76

mg/mmol

0.14

463

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

326

1.12

0.31

1.2

1.3

20.88

20.92

mmol/l

0.02

257

(40768446) Kidney Pathology biopsy report

222

1581

0.95

0.31

1.9

1.7

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

598

0.92

0.31

1.3

1.2

1.78

1.66

mmol/l

0.29

377

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.29

0.31

2.2

2.1

28.92

27.07

0.20

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

346

1.11

0.30

1.0

1.1

1.14

1.18

mom

0.22

346

(3044416) Complement C4 [Mass/volume] in Pleural fluid

148

0.82

0.30

1.6

1.1

0.05

0.08

g/l

1.95

105

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

244

1.14

0.30

1.1

18.71

17.04

iu/ml

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1089

7525

0.98

0.30

1.5

1.6

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.77

0.28

1.5

1.4

10.24

8.74

mg/l

—

(3050794) Legionella sp Ab [Presence] in Serum

316

1.11

0.28

1.2

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

110

0.80

0.28

1.1

1.0

11.00

12.04

mg/l

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

713

4700

1.03

0.27

5.9

6.5

11.21

11.61

mg/l

1.53

668

4361

(3006462) Nitrate [Presence] in Urine

239

1545

1.05

0.27

2.6

3.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

479

3140

1.03

0.26

1.4

1.5

—

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

1.24

0.26

7.9

8.7

42.17

43.46

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

153

0.84

0.26

1.0

0.01

0.34

u/ml

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

132

1.18

0.26

1.3

1.2

—

(3000285) Sodium [Moles/volume] in Blood

606

0.93

0.26

1.2

138.60

138.32

mmol/l

0.27

509

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

164

1.15

0.26

1.0

1.1

0.07

1.25

u/ml

1.72

164

(3011335) Digoxin [Mass/volume] in Serum or Plasma

210

0.87

0.26

2.5

2.3

0.60

0.67

ug/l

0.73

210

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

306

2148

0.96

0.25

2.6

2.8

42.17

39.37

1.97

154

1181

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

351

1.10

0.25

1.1

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

190

1.14

0.25

1.5

1.3

1.68

1.65

mg/l

0.07

162

(3029396) Erythrocyte agglutination [Presence] in Blood

203

1310

1.05

0.25

3.0

3.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

390

1.09

0.25

3.0

2.4

—

(3006969) Lambda light chains [Mass/volume] in Urine

1.22

0.25

1.3

1.1

0.20

0.05

g/l

—

(40762814) Titanium [Mass/volume] in Blood

478

0.92

0.25

2.7

2.5

3.12

3.68

ug/l

0.69

185

(4133840) Spirometry

141

1006

0.95

0.24

1.1

1.2

—

(3014271) Vancomycin [Susceptibility]

199

1407

0.96

0.24

2.8

2.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

248

1744

0.96

0.23

1.5

1.9

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

136

0.85

0.23

1.0

0.04

0.78

u/ml

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

241

1694

0.96

0.23

1.6

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

241

1694

0.96

0.23

1.6

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

705

4662

1.02

0.22

2.5

20.85

27.73

iu/ml

1.26

426

(3026480) Teichoate Ab [Titer] in Serum

289

1.10

0.22

1.1

—

2.83

—

(1175312) AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.22

0.0

1.0

—

(1176058) AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.22

0.0

1.0

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3003220) Varicella zoster virus IgG Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

712.50

—

(3025577) Chromium [Mass/volume] in Blood

237

1664

0.96

0.22

2.2

2.46

2.38

ug/l

0.14

201

1385

(3026470) Cobalt [Mass/volume] in Blood

244

1712

0.96

0.21

2.3

2.2

3.63

3.71

ug/l

0.06

230

1581

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

167

1.13

0.21

1.1

1.0

0.07

0.16

u/ml

0.71

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

180

1.13

0.21

15.6

11.8

104.50

105.66

g/l

0.23

180

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.21

0.0

1.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

744

4929

1.02

0.21

3.1

2.9

99.96

605.69

u/ml

1.68

734

4874

(46235479) Bilirubin fractions panel [Moles/volume] - Serum or Plasma

0.00

0.20

0.0

1.1

—

41.80

—

(3025311) HLA-B [Type]

0.00

0.20

0.0

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.79

0.20

1.0

1.1

1.00

1.31

u/field

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.24

0.20

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

136

1.14

0.20

1.2

1.1

227.18

291.80

nmol/l

0.83

136

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

143

1.13

0.19

1.0

0.06

0.48

u/ml

1.71

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

153

1080

0.96

0.19

2.1

2.0

2.03

1.77

ratio

1.02

143

1045

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

275

0.91

0.19

3.0

2.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

227

1.10

0.19

1.6

1.7

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

108

768

0.95

0.18

1.3

1.4

27.09

58.76

g/l

0.71

591

(3001964) Herpes simplex virus Ag [Presence] in Specimen

157

1019

1.04

0.18

1.4

1.5

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

196

0.90

0.17

1.1

1.3

415.90

1031.74

u/l

0.59

174

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

277

1819

1.03

0.17

7.5

6.5

846.11

2969.62

u/ml

0.55

338

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.75

0.17

3.0

2.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.16

0.17

1.0

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

151

1.12

0.17

1.1

1.0

0.08

0.09

u/ml

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

146

0.88

0.17

1.1

1292.11

4692.18

ng/l

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

537

0.94

0.16

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

250

1740

0.97

0.16

1.5

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

250

1740

0.97

0.16

1.5

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

250

1740

0.97

0.16

1.5

1.9

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

367

1.07

0.16

1.1

734.07

273.44

u/ml

0.92

(3013166) Neutrophils/Leukocytes in Synovial fluid

141

916

1.04

0.16

1.4

48.06

54.72

1.22

115

787

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

113

1.14

0.16

1.0

1.1

166.63

227.30

pmol/l

—

(3017354) Segmented neutrophils/Leukocytes in Blood

546

3624

1.02

0.15

2.7

3.4

56.63

57.17

0.25

459

3128

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

445

0.94

0.15

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

187

0.90

0.15

3.4

3.6

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

540

1.05

0.15

4.8

5.5

39.35

44.29

ug/min

0.28

426

(3004451) EKG impression Narrative

276

1819

1.03

0.14

1.3

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

235

0.92

0.14

9.0

5.0

—

(3035082) Kappa light chains [Mass/volume] in Urine

1.14

0.13

1.2

1.1

0.01

0.13

g/l

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

101

0.87

0.13

4.1

5.6

1.98

1.31

mg/l

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

344

2278

1.02

0.13

1.4

12.26

12.82

u/l

0.84

337

2204

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

414

0.95

0.12

1.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

451

1.05

0.12

1.4

1.3

5.71

5.79

mmol/l

0.33

451

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

189

1244

1.03

0.12

1.8

2.1

40.40

g/l

0.00

189

1244

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1664

11158

1.01

0.12

2.5

2.6

—

(3003157) Bacteria [#/volume] in Mother's milk

0.86

0.12

7.2

6.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

300

2070

0.98

0.12

1.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2185

14875

0.99

0.12

3.4

3.6

25.14

25.30

mmol/l

1.41

2103

14384

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.16

0.11

1.0

1.1

83.00

89.05

u/ml

—

(3024869) Neuronal Ab [Presence] in Serum

599

1.04

0.11

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

526

1.04

0.11

1.3

1.6

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

197

0.93

0.10

1.1

1.2

—

438.57

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

281

1.06

0.10

1.2

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

527

1.04

0.10

1.5

1.7

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

500

0.96

0.10

1.7

2.5

2.67

2.51

0.17

493

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

361

1.05

0.10

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

421

1.04

0.10

1.3

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.13

0.10

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

783

5239

1.01

0.10

1.6

1.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

309

2125

0.98

0.10

1.2

1.4

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

126

876

0.97

0.09

1.3

46.19

39.65

1.07

584

(3006567) Chloride [Moles/time] in 24 hour Urine

1.14

0.09

1.3

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

615

1.03

0.09

6.0

7.1

70.45

69.66

0.12

465

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

116

762

1.03

0.09

1.3

1.2

437.13

302.58

pmol/l

0.47

568

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

106

696

1.03

0.09

6.6

6.1

5866.88

5910.04

iu/ml

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.08

0.08

1.0

1.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.08

0.08

1.7

1.0

1.29

1.27

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

124

858

0.98

0.07

1.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

185

1.06

0.07

12.8

10.4

94.00

216.78

e6/l

1.09

128

(3007916) DNA double strand Ab [Titer] in Serum

432

1.03

0.07

1.3

102.80

144.68

titre

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

179

1.06

0.06

1.0

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.86

0.06

4.6

4.0

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

146

1.07

0.06

1.0

1.1

0.04

0.35

mg/l

0.52

124

(3013762) Body weight Measured

113

1.08

0.06

1.1

1.2

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.10

0.06

1.2

20.73

30.54

mg/l

1.68

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

576

3863

1.01

0.06

1.1

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

233

0.96

0.05

1.1

1.2

15.88

24.67

—

(3009871) Measles virus Ab [Titer] in Serum

227

1516

1.01

0.05

1.6

3177.14

3514.91

titre

0.24

250

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

134

1.06

0.05

1.0

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

316

2156

0.99

0.04

1.2

1.4

—

(37021550) Renin [Units/volume] in Plasma --upright

102

677

1.02

0.04

1.3

50.78

86.91

mu/l

1.35

509

(3026726) Creatinine [Moles/volume] in Specimen

268

1.03

0.04

2.1

2.4

436.41

390.29

umol/l

0.11

260

(3042631) Mycobacterium sp identified in Specimen

614

4174

0.99

0.04

2.8

2.7

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

443

3015

0.99

0.04

2.7

2.8

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1033

6956

1.00

0.04

1.4

1.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

585

0.98

0.03

2.3

2.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

646

4348

1.00

0.03

1.5

1.6

—

(3036670) Protein [Mass/volume] in Synovial fluid

146

976

1.01

0.03

1.2

1.3

39.59

40.14

g/l

0.17

518

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

512

1.02

0.03

1.1

1.3

34.14

42.46

mg/l

1.09

440

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

121

0.95

0.03

1.1

2.60

1.06

u/field

—

(3004959) Base excess in Arterial cord blood by calculation

183

1.03

0.02

1.0

1.1

-2.00

-2.17

mmol/l

0.04

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

492

3337

1.00

0.01

1.6

1.8

—

(3006598) pH of Arterial cord blood

184

1.03

0.01

1.0

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

164

1116

0.99

0.01

3.0

3.3

43.92

44.82

0.23

164

1116

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

164

1116

0.99

0.01

6.0

6.6

9.10

8.75

0.31

164

1116

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

814

5492

1.00

0.01

3.0

3.9

36.06

38.68

u/ml

0.14

785

5303

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

238

1.02

0.01

1.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

878

5947

1.00

0.01

1.6

1.7

—

(3016228) CD19 cells/cells in Blood

202

1373

0.99

0.01

2.0

2.1

8.61

8.31

0.16

194

1343

(3046861) Legionella sp Ag [Presence] in Urine

218

1.02

0.01

1.2

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

450

3038

1.00

0.00

1.3

6.40

6.26

mmol/l

0.49

420

2826

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

653

0.99

0.00

1.8

2.37

3.42

ug/l

0.53

418

(40763480) Human metapneumovirus Ag [Presence] in Specimen

156

1.00

0.00

1.0

1.4

—

(40762887) Creatinine [Moles/volume] in Blood

252

0.99

0.00

1.2

1.5

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.02

0.00

1.1

1.2

292.07

272.89

u/ml

0.17

(3017461) Flecainide [Moles/volume] in Serum or Plasma

189

1.00

0.00

1.4

1.8

0.65

0.71

umol/l

0.32

144

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.99

0.00

1.0

1.1

—

(3020618) Glucose [Moles/volume] in Synovial fluid

118

0.97

0.00

1.1

4.52

4.98

mmol/l

0.33

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.04

0.00

6.2

5.5

0.15

0.24

mmol/l

0.92

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

126

1.02

0.00

1.1

1.3

1.00

1.16

u/field

0.34

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

463

1.01

0.00

1.1

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

109

734

1.00

0.00

2.7

206.71

399.71

ug/l

0.34

109

734

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

394

2660

1.00

0.00

1.8

3.44

3.72

mg/l

0.66

375

2555

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.02

0.00

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.03

0.00

7.2

8.3

—

(3022912) Hexacarboxylporphyrin [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(40771459) Voltage-gated potassium channel Ab [Moles/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.86

-0.00

1.0

1.1

1005.00

2043.83

titre

—

(3035963) Corticotropin [Moles/volume] in Plasma

0.00

-0.00

0.0

1.0

—

8.78

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.94

-0.00

1.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

0.97

-0.00

1.1

—

(3032940) Amino acids [Identifier] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.95

-0.00

1.1

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: F5_BEHAVE – Behavioural syndromes associated with physiological disturbances and physical factors

GWS hits: 9

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Behavioural syndromes associated with physiological disturbances and physical factors

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints